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ABSTRACT 
The influenza virus is a common respiratory pathogen with the capacity to cause global 
pandemics affecting millions of people, contributing substantially to overall mortality and 
morbidity. Thus, considerable research focuses on the prevention and treatment of influenza virus 
infection. Despite the availability of vaccines, influenza infection continues to be a common illness 
due to its ability to rapidly mutate and reassort, introducing novel strains. Focusing on host factors 
that are exploited by the virus could lead to the development of new therapeutics with lower 
potential for drug resistance and confer universal strain potency.  
Sphingolipids are a host lipid that is a known influenza target. According to a long-standing 
hypothesis, cholesterol and sphingolipids form distinct plasma membrane domains, termed lipid 
rafts, that help recruit newly synthesized influenza components to virus assembly sites for 
progeny budding. However, the sphingolipid and cholesterol abundance at this bud zone remains 
a mystery due to the limited means to image these lipids in the plasma membrane without using 
labels that may alter their distributions or functions. Recently, a high-resolution secondary ion 
mass spectrometry approach was used to image stable isotope-labeled cholesterol and 
sphingolipids in the plasma membranes of fibroblast cells with sub-100 nm lateral resolution. 
These reports established that sphingolipid domains do not have elevated cholesterol levels, 
calling into question this hypothesis. We use this technique to show for the first time that the 
influenza virus does not bud from sphingolipid-enriched domains in the plasma membranes of 
whole cells. Further experiments also revealed the intracellular 3-dimensional distributions of 
cholesterol and sphingolipids within a cell with high resolution. This new imaging capability will 
expand our knowledge of the intricate network of these lipids and help shape our understanding 
of their exploitation during infection.  
Sphingolipids are key influenza targets, however, this research indicates that they are not 
targeted at the plasma membrane, specifically, to recruit viral components for budding. We also 
discuss the role of ceramide, a central sphingolipid in the sphingolipid biosynthesis pathway, in 
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the influenza lifecycle. Our analyses indicate the need for further studies on ceramide as a 
potential target of the influenza virus through its regulatory enzymes.  
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CHAPTER 1. 
INTRODUCTION 
Influenza Virus 
Influenza A virus is a common pathogen of the respiratory track resulting in “the flu.” The 
influenza virus is an enveloped, negative-stranded RNA virus that typically infects ciliated 
columnar epithelial cells of the upper respiratory tract.1,2 Human influenza virus first gains entry 
into a cell through interaction with α-2,6-linked sialic acid receptors present on multiple receptors.3-
6 This interaction is mediated through hemagglutinin (HA), a viral integral membrane protein, that 
also functions as a fusion protein during viral entry.7 Once internalized, acidification of the 
endosome triggers a conformation change in HA which then mediates the fusion of the virus and 
endosomal membrane, releasing genetic components or viral ribonucleoprotein (vRNP) 
complexes.7,8 Using a range of host factors, vRNPs are trafficked and imported into the cell 
nucleus.9 Following replication of the viral genome within the cell nucleus,10 assembly and 
budding of progeny virus are the latest and crucial steps in the viral life cycle.11 Influenza is 
believed to exploit specific membrane regions of the cell in order to recruit viral proteins to 
assembly sites.12 These plasma membrane regions then serve to form the viral envelope, a virion 
component crucial to infectivity and survival.13,14 Many current anti-influenza strategies target 
these key aspects of its lifecycle, however, the flu continues to be of considerable clinical interest.   
Flu accounts for more than 200,000 hospitalizations and the death of more than 30,000 
people within the United States each year.15 Despite preventative measures, such as annual 
vaccination, statistical analysis estimate that medical costs associated with the illness surpass 
ten billion dollars annually.16 The virus’s ability to rapidly mutate and reassort accelerates the 
emergence of novel antigenic subtypes that are highly pathogenic7,17 or resistant to drugs that 
target the influenza virus proteins.18 This is due, in part, to the fact that the influenza virus has a 
segmented genome,19 which allows the packaging of mixed gene segments exchanged between 
different influenza variants into a single progeny virion.20 This ability to reassort genetic 
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components increases the likelihood of new antigenic strains.21 Novel antigenic strains of the 
influenza virus allow it to evade pre-existing immunity from previous infection of a differing 
influenza subtype or vaccination.7 Influenza, like other RNA viruses, also exhibits high rates of 
mutation due to its error-prone genome replication, which can introduce mutations.20,22 Strains 
with novel antigenic characteristics can quickly infect global populations, causing pandemics. 
Pandemic influenza strains have the potential to kill millions of people worldwide as evidenced by 
the 1918 influenza pandemic.23 These strains have the potential to infect nearly half the population 
in a single flu season.7 The most recent 2009 H1N1 pandemic influenza strain was estimated to 
have affected 61 million people during the 2009 flu season.24 Thousands of lives could be saved 
each year by exploiting key mechanisms and pathways the virus needs, leading to novel targets 
for drugs and antivirals.7,11,12,17 Focusing on the host factors that do not mutate at the high 
frequencies seen in RNA viruses and are crucial to the infection may lead to new therapeutics 
with lower potential for drug resistance and potency towards most influenza strains. 
Interactions of Influenza Virus and Host Lipids 
Much research has focused on the cell membrane and its importance in the influenza 
lifecycle, particularly its exit. Researching viral budding from the cellular membrane is essential 
to prevent disease as assembly and budding of the virus particles are the last but critically 
important steps in the influenza lifecycle for both the survival of the virus as well as its disease-
producing ability in the host.11,12,25,26 The cell membrane is a complex mixture of lipids and proteins 
that create a bilayer and is used for multiple functions including signal transduction,27 adhesion,28 
and vesicle transport.29 Budding gold-immunolabeled HA of newly forming progeny virus has been 
detected in a “highly nonrandom distribution,” suggesting selective delivery of HA to specific 
microdomains within the cellular membrane.30 This, along with the finding that the envelope the 
influenza virus acquires when it buds is enriched with cholesterol, sphingolipids31 and viral 
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proteins, led to the hypothesis that it assembles and buds at plasma membrane microdomains 
that are thought to be enriched in cholesterol and sphingolipids.11,12,25,26,32 
Ordered sphingolipid- and cholesterol-enriched regions that hypothetically exist within the 
plasma membrane are referred to as lipid rafts. In addition to their postulated role in influenza 
virus assembly and budding, they are also hypothesized to mediate important cellular processes 
in healthy cells, such as cell signal transduction.33 The prevalent hypothesis for the sensitivity of 
influenza virus replication to cellular sphingolipid levels is that sphingolipids are involved in the 
recruitment of the viral proteins to the site of virus budding. In this hypothetical mechanism, 
favorable interactions between sphingolipids and cholesterol are postulated to induce the 
formation of highly ordered membrane domains that are enriched with these two components.34,35 
HA, an influenza virus envelope protein that is integral to virus infectivity,36,37 is postulated to have 
an affinity for cholesterol and sphingolipids, which promotes HA recruitment to lipid rafts, and 
subsequent virus assembly and budding. Consistent with this hypothesis, influenza buds only 
from the apical plasma membrane side,11 which is believed to be enriched with lipid rafts.38 
Likewise, HA clusters in areas of the plasma membrane that are enriched with one type of 
sphingolipid, the ganglioside GM1, and this clustering is reduced by depletion of cellular 
cholesterol and mutations in HA’s transmembrane domains.39,40 Moreover, disruption of this 
clustering reduces virus budding and infectivity.40 Other support for this hypothesis includes the 
cholesterol- and sphingolipid-sensitive transport of influenza proteins to the plasma membrane.41-
43 Although these observations are indirect evidence for influenza-raft interactions, a concrete link 
is still lacking.  
Experiments to test the lipid raft hypothesis have been ongoing for decades, with detergent 
extraction once serving as a common method to demonstrate their existence and probe stimuli-
induced changes in their composition.44 Lipid rafts were thought to be insoluble in cold detergents 
due to the tight packing between cholesterol and sphingolipids.45 Therefore, detergents were used 
to solubilize the non-raft regions of the intact cell membrane, allowing isolation of the detergent-
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resistant lipid rafts.44,46,47 Viral HA was found to associate with these detergent-resistant 
membranes.48 However, the isolation of components found in detergent-resistant membranes is 
vastly dependent on the methods and type of detergent used in the study49-51 and even 
temperature.52 Skepticism in the extraction method grew, and studies eventually demonstrated 
that detergent-resistant membranes are products of artificial aggregation that were not present in 
the living cell.52-55 Consequently, the evidence for influenza employing cholesterol- and 
sphingolipid-enriched domains for budding is indirect, and subject to interpretation. 
The hypothesis that the influenza virus buds and obtains its envelope from cholesterol- and 
sphingolipid-enriched regions within the plasma membrane is implied from indirect data42,56-65 and 
has not been directly tested. The distributions of cholesterol, sphingolipids, and influenza virus 
proteins in the plasma membrane remains a question due to the incapability to image each 
component in parallel without using fluorophores that may alter lipid trafficking and distribution.66,67 
Recently, high-resolution secondary ion mass spectrometry (SIMS) has enabled the  imaging of 
stable isotope-labeled cholesterol and sphingolipids in the plasma membranes of fibroblasts with 
87-nm lateral resolution.68 This study established that the plasma membranes of murine fibroblast 
cells contain sphingolipid domains that are not enriched with cholesterol.68 Moreover, this 
technique was also used to discover that influenza virus HA does not cluster in domains that are 
enriched with cholesterol and sphingolipids in the plasma membranes of virus-free murine 
fibroblast cells that stably express HA protein.69 These findings are inconsistent with the 
hypothesis that the newly synthesized influenza components are recruited to pre-existing 
membrane domains that are enriched with sphingolipids and cholesterol.  
This dissertation focuses on the intricate relationship of the influenza virus with key lipids, 
cholesterol and sphingolipids, using high-resolution SIMS for chemical imaging of the plasma 
membrane and influenza bud sites along with complementary biochemical techniques. High-
resolution SIMS is discussed in more detail in Chapter Two as it was used to image budding 
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influenza virus from whole cells and Chapter Three as it is used to explore the intracellular 
distributions of cholesterol and sphingolipids in a portion of a cell. 
Alternative Hypotheses for Dependency of Influenza Virus Replication on Cholesterol and 
Sphingolipids 
While the envelope that the influenza virus acquires when it buds has been shown to be 
enriched with the host cell’s cholesterol and sphingolipids31 as well as viral proteins, whether the 
plasma membrane donor sites are enriched with these lipids has not been established. Given that 
the viral envelope is crucial to virus infectivity and survival in the environment,13,14 and influenza 
virus assembly requires sphingolipid biosynthesis,41,43 identifying the precise roles of cholesterol 
and sphingolipids in the influenza replication cycle is imperative to fully understand the intricate 
virus-host interactions that may be exploited by novel drugs and therapeutics. 
A large body of research has probed the role of lipid rafts in influenza infection, but much 
less research has explored alternative mechanisms to explain the sensitivity of the influenza 
replication to the host cell’s cholesterol and sphingolipid levels. Concluding that the disruption of 
lipids at the plasma membrane by cholesterol sequestering is the only explanation for decreased 
infectivity is probably an oversimplification. Cholesterol has many pleiotropic effects on cellular 
function and is vital to many processes ranging from the regulation of protein activity70 to cell 
polarization.71 Sphingolipids function not just as plasma membrane components, but also as 
precursors to signaling molecules that regulate a wide range of biological processes.72 Thus, the 
cholesterol and sphingolipids levels may influence influenza replication through a mechanism that 
does not directly involve their functions as major plasma membrane components.     
Cholesterol May Influence Influenza Virus Replication by Regulating Protein Trafficking  
As mentioned previously, cholesterol serves as a major lipid of the influenza virus envelope, 
but its relative levels in the host cell have been implicated in virus entry and affect the infectivity 
of the progeny virions.73 This viral dependence on cholesterol may be explained by cholesterol’s 
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complex role in trafficking.74 For example, the correct transport of influenza HA to the apical 
plasma membrane is dependent on cholesterol.42 Annexin A6 is a membrane binding protein 
linked to the regulation of membrane recognition and trafficking and a key player in the 
maintenance of cellular cholesterol homeostasis.75 Annexin A6 impairs influenza replication 
through its actions on plasma membrane cholesterol levels.75 More recently, the transport of the 
influenza virus genome was associated with cholesterol-enriched recycling endosomes.76 
Cholesterol accumulation at these recycling endosomes was found to be induced by the virus and 
disruption of this cholesterol accumulation was correlated with defective bud site formation.76  
Sphingolipids May Modulate Interactions between the Influenza Virus and the Host Cell’s 
Cytoskeleton 
Cytoskeletal remodeling is essential for influenza replication.77,78 The host cytoskeleton is a 
necessary component for viral entry at the start of infection, the transport of new components to 
the plasma membrane for assembly, and budding of the virus at the end of the life cycle.77,78 High-
resolution SIMS studies indicate the cytoskeleton and its associated proteins are responsible for 
plasma membrane organization.68,79 Cytoskeletal components, including actin, a major filament 
that makes up the cytoskeleton, is intimately linked to the influenza life cycle.77 Actin is required 
for HA clustering in the cell plasma membrane80 and its interaction with influenza nucleoprotein 
(NP) may act as a cell cytoplasm retention signal, facilitating the localization of the viral genetic 
complex for eventual assembly and budding.81,82 The cytoskeletal proteins actin, tubulin, and 
cofilin have all been found within the interior of influenza virions, suggesting they have an active 
role in influenza virus assembly.83 Therefore, factors that regulate the cytoskeleton and its 
associated components may be attractive anti-influenza drug targets. 
Ceramide is a sphingolipid second messenger that is involved in cytoskeletal remodeling.84-
86 Neutral sphingomyelinase (nSMase) is a regulating enzyme of ceramide that cleaves 
sphingomyelin, producing ceramide and phosphocholine.87-90 The resulting ceramide is a second 
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messenger that facilitates membrane fusion and budding,91 key steps in the influenza life cycle. 
Ceramide has been linked to the dephosphorylation of ezrin, radixin, and moesin (ERM)84-86 that 
serve to facilitate plasma membrane and cortical actin cytoskeleton interactions.92 Ceramide 
accumulation can induce actin cytoskeletal rearrangement in cells resulting in the loss of cell 
polarity.93 Ceramide-induced actin changes can cause the disintegration of actin-based cell 
protrusions and impair cell motility.93 In addition to influencing the cytoskeleton, ceramide also 
induces vesicle formation in giant liposomes, which lack cytoskeletons, by inducing membrane 
curvature.94 This biophysical property is hypothesized to be exploited by Neisseria gonorrhoeae 
whose entry into a cell was dependent on SMase activity at the cell plasma membrane.91,95 Other 
pathogens have been shown to manipulate ceramide production through sphingomyelinase 
regulation because of its intimate link to the cytoskeleton and its intrinsic vesicle-forming 
properties.93,95 These aspects of ceramide make it a promising candidate important in the 
replication of influenza that could be exploited by pharmacological inhibitors. Chapter Four details 
the findings on the effects of nSMases on the influenza virus lifecycle and discusses the 
implications of these results and future directions for this work.  
High-Resolution Secondary Ion Mass Spectrometry (SIMS) to Test whether Influenza Virus 
Buds from Cholesterol- and Sphingolipid-Rich Domains 
Much research has focused on the cellular membrane sites from which influenza buds in 
order to release progeny virions as a potential stage of infection to disrupt with antivirals; however, 
current methods of research are limited in their abilities to accurately analyze these tiny sections 
of plasma membrane and have created a hotly debated topic among fellow researchers.25,26   
While the hypothesis that the influenza virus buds and obtains its envelope from cholesterol- and 
sphingolipid-enriched regions within the plasma membrane is implied from indirect data,42,56-65 the 
distributions of cholesterol, sphingolipids, and viral proteins in the plasma membrane remain a 
question due to the incapability to image each component in parallel without using fluorophores 
8 
 
that may perturb the lipids.5,97,98 High-resolution SIMS has enabled the imaging of stable isotope-
labeled cholesterol and sphingolipids in the plasma membranes of fibroblasts with 87-nm lateral 
resolution.68 This study established that the plasma membrane contains sphingolipid domains that 
are not enriched with cholesterol, and cholesterol is instead evenly distributed in the plasma 
membrane.68 Moreover, this technique was also used to show that influenza virus HA does not 
cluster in sphingolipid-enriched domains in the plasma membranes of virus-free cells that stably 
express viral HA.69 These findings are inconsistent with the hypothesis that the newly synthesized 
influenza components are recruited to pre-existing membrane domains that are enriched with 
sphingolipids and cholesterol.  
Secondary ion mass spectrometry enables the imaging of the distributions of biomolecules 
in a cellular membrane without the use of fluorophore labels, and a variety of SIMS techniques 
have been used to image the chemical composition of biological samples, such as tissue, for 
decades.96 In general, SIMS employs a primary ion beam to sputter neutral and ionized whole 
and fragmented molecules from the surface of a sample. The ejected secondary ions are 
detected, and their intensities are used to map the parent molecules’ distributions on the surface 
from which they were expelled.  
High-resolution SIMS performed on a NanoSIMS has enabled significant progress in imaging 
biomolecules in single, whole cells. In particular, the lipid organization in biological membranes 
has been imaged without the use of fluorophores, and with a lateral resolution better than 100 
nm.69,97 In this instrument, a cesium primary ion beam is scanned over the sample (i.e., a cell). 
Monoatomic and diatomic secondary ions, which are charged fragments of the molecules, are 
sputtered from the sample’s surface. Ions with up to five different mass-to-charge ratios (m/z) are 
collected in parallel at each pixel by a magnetic sector mass spectrometer that can differentiate 
interfering isobars of the same nominal mass (i.e. 12C15N−, 26.9996 amu versus 13C14N−, 27.0059 
amu). The intensities of these secondary ions are then used to map the elemental and isotopic 
composition at the sample surface. Because this instrument detects monoatomic and diatomic 
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secondary ions, each biomolecule of interest must contain a distinct stable isotope or non-native 
element so that the secondary ions generated during the analysis can be linked to the parent 
molecule. The distinct stable isotopes that encode for component identity are selectively 
incorporated into the lipid species of interest with established metabolic labeling techniques.98-100 
On the cellular scale, SIMS can be utilized to detect these labeled molecules that are, in most 
biological processes, indistinguishable from unlabeled biomolecules.101,102 NanoSIMS 
instruments have been successfully implemented in a variety of biological studies to investigate 
isotope-labeled metabolites in cultured cells.68,79,101-103 
SIMS is performed under ultra-high vacuum, so sample preparation methods that preserve 
the intricate organization of the cellular membrane are required. SIMS techniques are able to 
attain biochemical information with high spatial and lateral resolution, and so, ensuring the native 
distributions of molecules of interest within intact samples is imperative. Cell preservation 
procedures have long been used in countless experiments over many years and numerous 
studies have aimed to validate each. The cryopreservation of biological samples for SIMS 
analysis was first described by Chandra and coworkers.104 In this publication, the cells were 
freeze-fixed in a liquid nitrogen slush, and maintained at these temperatures before and during 
SIMS analysis to avoid dehydration, which can induce the redistribution of molecules and tissue 
distortion.104-106 Noteworthy, rapid freezing is essential to minimize the formation of crystalline 
water, which ruptures biological membranes and displaces native molecule distribution.107 
Consequently, liquid propane or ethane (melting points are -185 °C and -188 °C, respectively) 
which have higher heat capacities than liquid nitrogen, are now used in place of liquid nitrogen in 
order to maximize the formation of vitreous ice.108 Subcellular analysis can be carried out after 
freeze-fixing and fractionation of whole cells using a sandwich-fracture technique104,109 or by 
common thin cryosectioning practices. Such frozen-hydration methods are thought to preserve 
even highly diffusible ions, such as sodium and potassium.110 
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Extreme care must be taken to avoid thawing frozen samples, as alterations in some ion 
signals have been observed in thawed samples.110 Indeed, the thawing of frozen, cryosectioned 
samples under vacuum before analysis leads to the extensive migration of even larger molecules, 
such as cholesterol, through the tissue.111 Many groups now use protocols to fracture freeze-fixed 
samples in vacuo and pre-cooled stages during analysis so that samples are never exposed to 
environments conducive to water crystal formation. Lanekoff and coworkers were the first to 
describe an in situ freeze fracture device with a spring-loaded trap system for a time-of-flight SIMS 
(ToF-SIMS) instrument. Using this mechanical device, frozen-hydrated samples are fractured 
within the trap system after being placed in the analysis chamber of the ToF-SIMS instrument, 
minimizing sample exposure to ambient atmosphere.108 A cold stage has yet to be developed for 
existing NanoSIMS instruments.112 
Chemical fixation, while popular in the preparation of histological tissues, is less favored for 
ToF-SIMS because it uses chemical bonds to immobilize the molecules within the sample, and 
this bonding often changes the distinctive molecular fragmentation patterns that are used to 
identify the species of interest. High-resolution SIMS performed with the Cameca NanoSIMS 50 
uses distinct isotopes to label the molecules of interest to identify parent molecules from their 
monoatomic and diatomic ions and are affected minimally by chemical fixation. Chemical fixation 
protocols are easy to execute and are very attractive because the samples may be stored and 
analyzed at room temperature, barring the need for the rigorous sample-environment regulation 
required for cryopreservation methods. While many chemical fixatives exist, only well-established 
fixation methods are discussed below. 
Glutaraldehyde has been widely used since its introduction as a cell fixative many decades 
ago by Sabatini, Bensch, and Barrnett.113 Glutaraldehyde is known to cross-link proteins, notably 
through lysine residues.114,115 This reaction is irreversible with minimal protein denaturation,116 
evidenced by retained catalytic activity following precise glutaraldehyde treatment.117 While 
glutaraldehyde’s reactivity with lipid species has not been explored to the extent of proteins, it has 
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been found that glutaraldehyde did prevent the loss of phosphatidylserine and 
phosphatidylethanolamine upon extraction in glutaraldehyde-fixed rat tissue, presumably through 
the fixative’s interactions with free amino groups of proteins and phospholipids.118 While used 
extensively to fix samples for light or electron microscopy,119,120 glutaraldehyde should be 
supplemented with another fixative when complete cessation of movement of the lipid bilayer in 
cells is required. Using spin-labeling techniques on nerve cells, glutaraldehyde was found to 
restrict molecular motion of only those spin labels coupled to a protein component, but did not 
grossly alter the fluidity of the lipid bilayer.121 Coupling glutaraldehyde fixation, to crosslink 
proteins, and osmium tetroxide, to crosslink lipids, is the pinnacle of chemical fixation 
techniques.122 Osmium tetroxide reacts with the double bonds of unsaturated lipids, crosslinking 
them together.123-126 These linkages severely hinder the molecular motion of lipids in 
multilayers121,127 and nerve tissue.121 Osmium tetroxide has even been found to preserve the 
delicate bilayer organization of the plasma membrane of cells.128,129 We have shown that 
glutaraldehyde fixation does not alter lipid distributions in the plasma membrane of cells.68  
Three-Dimensional Imaging with High-Resolution SIMS 
3-Dimensional (3D) imaging of single cells is an important step in the understanding of 
complex biological processes of cells and their organelles. Lipids and cholesterol, which comprise 
the cellular plasma membrane, have also been found to be important in signal transduction130,131 
and intracellular trafficking.132,133 The proper organization and composition of these species within 
cellular compartments has been linked to a variety of medical disorders.134-137 Direct imaging of 
the lipid and cholesterol composition of intracellular compartments without the use of fluorophores 
that may alter organization67,138,139 is imperative to study their native organization. SIMS provides 
an attractive means to image 3D structures, as repeated sputtering of material from the sample 
surface at a given location allows the creation of layered maps of component distributions at 
progressively increasing depth in the sample. 
12 
 
Most 3D reconstruction of whole cells has been accomplished using ToF-SIMS. Unlike high-
resolution SIMS performed on a NanoSIMS, ToF-SIMS uses a time-of-flight mass analyzer to 
collect the ejected secondary ions. This analyzer enables the collection of high mass fragment 
ions that are distinctive to the molecule of interest, which eliminates the need to use distinct 
isotope labels for component identification. ToF-SIMS has been used to construct 3D images of 
biocompatible polymers,140 a Xenopus laevis oocyte,141 and HeLa-M cells.142 The use of cluster 
primary ion sources, such as Aun+ and Bin+, and polyatomic primary ions, such as C60+, has led to 
increased secondary ion yields that improve sputtering efficiency while decreasing the destruction 
of underlying material.143-146 While the improvement of ToF-SIMS as an imaging tool for single 
cells continues, challenges persist. Imaging single cells has proved difficult due to their inherent 
complex composition and surface features. Many intracellular structures fall well-below the 
general submicron lateral limitations of current ToF-SIMS instruments.147,148 Furthermore, isobaric 
interference from species with the same elemental composition may confound ToF-SIMS data, 
making interpretation challenging.142,149  
The 3D imaging capabilities of the NanoSIMS is a promising tool to enable examination of 
lipid distribution and how it changes during influenza infection. Prior to this thesis, the NanoSIMS 
instrument had not been used to image the cholesterol and sphingolipid distributions inside whole 
cells. Chemically imaging whole cells using NanoSIMS is advantageous because it has higher 
resolution than ToF-SIMS. A lateral resolution close to 50 nm is capable,147 enabling the resolution 
of far smaller intracellular features than was previously capable with other SIMS techniques. 
However, this makes image acquisition of entire cells significantly more time consuming. As a 
step in this direction, this thesis details how high-resolution SIMS, performed with a Cameca 
NanoSIMS 50, was used to directly image the 3D lipid organization within a portion of a MDCK 
cell. The 3D images that were generated show the intracellular distributions of both cholesterol 
and sphingolipids in a reconstructed representation of a portion of the cell. 
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Scope of the Thesis 
This thesis details the interactions of the influenza virus with host lipids, cholesterol and 
sphingolipids. This was accomplished through a variety of experiments, with an emphasis in 
experimentation using the Cameca NanoSIMS 50 instrument. In Chapter Two, NanoSIMS 
analysis of metabolically labeled cells with heavy isotopes to chemically image the cell mid-
infection was used to create a more accurate depiction of the influenza virus bud zone as it 
emerges from the cellular plasma membrane. The metabolic isotope labeling method as well as 
the infection parameters used are described. The goal of this work was to study the plasma 
membrane regions from which the influenza virus buds and gauge whether those sites were 
enriched with sphingolipids and cholesterol. 
Chapter Three discusses the use of NanoSIMS to chemically image the intracellular structure 
of a cell region. It details how the Cameca NanoSIMS 50 was used to elucidate the isotope-
labeled sphingolipid and cholesterol distributions at increasingly deeper layers within a cell and 
how the layers were used to reconstruct a 3D image. Interesting subcellular features are shown 
as well as a discussion on their potential importance within the cell. The goal of this work was to 
explore the capabilities of NanoSIMS analysis to further its use as a tool for lipid research. 
Chapter Four discusses the role of nSMases in the influenza virus infection. A variety of 
experiments are used to show the effects of pharmacological inhibition and genetic knock-down 
of nSMases on the replication of the influenza virus. The goal of this work was to clarify the specific 
role of nSMases in the influenza lifecycle in the hopes to characterize a potential drug target. 
Lastly, Chapter Five describes final conclusions that are drawn from this thesis as well as 
offers insights into future work. 
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1.2. FIGURE 
 
Figure 1.1 Schematic diagram of the Cameca NanoSIMS 50 instrument. The primary ion bean is 
focused on the surface of the sample. Positive and negative ions, depending on the primary 
source, are collected by coaxial optics. Monoatomic and diatomic secondary ions with up to five 
different mass-to-charge ratios (m/z) can be collected in parallel by the magnetic sector. 
Reproduced with permission from Annu. Rev. Biophys. 38 (2009) 53–74 (Ref 97). 
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CHAPTER 2. 
THE INFLUENZA VIRUS DOES NOT BUD FROM SPHINGOLIPID-DOMAINS THAT ARE 
ENRICHED WITH CHOLESTEROL IN THE PLASMA MEMBRANE OF MDCK CELLS 
2.1. INTRODUCTION1 
The influenza A virus is a common respiratory pathogen that is responsible for thousands of 
deaths each year.1 This enveloped, RNA virus is vaccinated against annually and is still estimated 
to cost billions of dollars each year in medical care associated with its prevention and treatment.2 
The influenza virus’s segmented genome allows repackaging of different gene segments from 
several subtypes into new progeny virus, leading to antigenic shifts.3,4 This, along with high rates 
of mutation, or antigenic drift, also leads to increased resistance to anti-viral therapeutics.4,5 These 
mutated antigenic strains allow it to avoid pre-existing immunity from previous infection and 
vaccination.4 Pandemic-causing strains have the potential to affect the entire globe. This was 
clearly demonstrated by the most recent 2009 H1N1 influenza pandemic strain, which has been 
estimated to have affected over 60 million people during the 2009 flu season alone.6 
Understanding the host factors exploited by influenza could pave the way for new therapeutics 
and drugs with universal potency and lower the risk of resistance. 
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Past efforts have identified the cell plasma membrane as a critical factor in the release of 
newly forming progeny virus. As discussed in Chapter One, the plasma membrane is widely 
believed to contain microdomains that are enriched in cholesterol and sphingolipids, termed “lipid 
rafts”, and the influenza virus hypothetically uses lipid rafts for its assembly, budding, and 
ultimately, to form its host-derived envelope.7-11 This idea of sphingolipid- and cholesterol-
enriched lipid rafts in the plasma membrane is intimately linked to the hypothesis that influenza 
virus buds from lipid rafts, with indirect evidence from each used to support the other’s existence. 
The lipid raft hypothesis first gained traction from the extraction of cholesterol- and sphingolipid-
enriched detergent resistant membranes (DRMs) from whole cells.12,13 The viral envelope protein, 
hemagglutinin (HA), was notably found to partition in these DRMs.14 Once this discovery was 
made, observations such as the clustering of influenza HA in seemingly nonrandom locations on 
the plasma membrane15 to the difference in lipid profiles of the influenza viral envelope and the 
envelope of a basolateral-budding virus,16 a site inferred to be devoid of supposed lipid rafts, was 
used to link influenza to the lipid raft hypothesis. The influenza virus is widely thought to exploit 
sphingolipid- and cholesterol-enriched membrane domains for the recruitment of viral 
components to assembly and budding sites.10 Favorable interactions between cholesterol and 
sphingolipids are hypothesized to induce the arrangement of highly ordered membrane domains 
enriched with these two lipid species.17,18 Due to the extraction of influenza HA in DRMs, HA was 
postulated to have an affinity for these highly ordered cholesterol- and sphingolipid-rich domains, 
which would target it to lipid rafts and thereby promote virus assembly and budding. The plasma 
membrane regions that are the site of influenza virus assembly and budding also form the virus 
envelope, a key viral component that is important to influenza infectivity and environmental 
survival.19,20  
Decisively testing the hypothesis that the influenza virus assembles and buds from so-called 
lipid rafts has proved challenging, with most experiments providing indirect proof that is subject 
to interpretation. Today, mounting doubt about the detergent extraction method calls into question 
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the significance of HA recovery in DRMs and whether these structures are just products of artificial 
aggregation.21 New efforts to compare the lipid composition of the influenza viral envelope and 
the plasma membrane of the host cell are fraught with major challenges. Presently, the apical 
plasma membrane cannot be cleanly separated from the rest of the cell without contaminating it 
with lipids from intracellular membranes, such as the endoplasmic reticulum and endosomes, 
highlighting the need for whole, intact cell imaging. While many fluorescent techniques exist, the 
use of bulky fluorophore labels may perturb the intracellular trafficking and subcellular distribution 
of these lipids.22,23  
Recently, a high-resolution secondary ion mass spectrometry (SIMS) technique was used to 
image stable isotope-labeled cholesterol and sphingolipids in the plasma membranes of whole 
cells with 87-nm lateral resolution.24 This study established that the plasma membranes of mouse 
fibroblast cells contain sphingolipid domains that are not enriched with cholesterol.24 This 
technique was also used to show that influenza HA does not cluster in the sphingolipid domains 
in the membranes of the virus-free cells that stably express HA.25 This finding directly contradicts 
the validity of inferring that HA has an affinity for cholesterol and sphingolipids based on the 
recovery of influenza HA in DRMs. This SIMS technique allows the direct imaging of cholesterol, 
sphingolipids, and, now, the influenza proteins at the site of virus budding. 
We now test the long-standing hypothesis that the influenza virus buds from plasma 
membrane domains that are enriched in cholesterol and sphingolipids by characterizing the 
chemical composition of the influenza virus bud sites on intact, stable isotope-labeled cells for the 
first time using high-resolution SIMS. This technique bypasses the need to isolate components, 
such as sphingolipid domains, from the plasma membrane of cells, thereby avoiding the 
subjectivity of inferring membrane composition from indirect data. In conjunction with our use of 
non-bulky stable isotope labels, which avoid the potential artifacts induced by fluorophore labels,26 
this technique creates a far more accurate picture of the budding zone during influenza virus 
infection compared to previous efforts.  
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In this work, we studied serum-free Madin-Darby Canine Kidney (MDCK) cells that were 
infected with the A/Aichi/2/68 (H3N2) strain of the influenza virus, a common H3N2 strain that is 
commercially available through the American Tissue Culture Collection (ATCC) and we cultivated 
according to established protocols.27 MDCK cells were selected as the host for this virus due to 
their common use to propagate influenza, their commercial availability, their high susceptibility to 
influenza virus infection and high production of the virus.28 In addition, much influenza research 
has been conducted using this cell line, so a breadth of knowledge of the many mechanisms of 
influenza pathogenesis in MDCK cells is readily available.27,29-33 For comparison, we also 
analyzed mock-infected cells that were not exposed to virus to validate our immunolabeling 
procedure, as well as uninfected MDCK cells that were not immunolabeled in order to establish 
the cholesterol and sphingolipid distributions in the plasma membranes of uninfected MDCK cells. 
From our results, we conclude that the influenza virus does not bud from sphingolipid-enriched 
domains found in the cell plasma membranes. Moreover, we conclude that while sphingolipid 
domains exist in the plasma membranes of MDCK cells, they are not enriched with cholesterol, a 
finding that is consistent with previously published reports of the lipid distributions in mouse 
fibroblast cells.24 
2.2. MATERIALS AND METHODS 
Materials  
Primary anti-influenza antibody was purchased from Takara Bio Inc. (monoclonal anti-
influenza A, H3N2, developed in mouse) and secondary immunogold antibody from Ted Pella, 
Inc. (20-nm gold, goat anti-mouse IgG). Trypsin was from Worthington Biochemical Corp. Fresh 
chicken blood was provided by the Department of Animal Sciences at the University of Illinois 
Urbana-Champaign. Fatty acid-free bovine serum albumin (BSA), 13C18-stearic acid (99 atom% 
carbon-13), and other cell culture materials were purchased from Sigma. V-bottom plates were 
purchased from Sarstedt. Poly-L-lysine and agents for chemical fixation were purchased from 
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Electron Microscopy Sciences. Uniformly carbon-13 labeled (98 atom%) fatty acids were 
purchased from Cambridge Isotope Laboratories and 5 x 5-mm silicon wafer chips from Ted Pella 
Inc. The 15N-sphingolipid precursors, 15N-sphingosine and 15N-sphinganine, were synthesized 
from 15N-serine that was purchased from Cambridge Isotope Laboratories.34-36 18O-Cholesterol 
was synthesized following repeated protocols from i-cholesteryl methyl ether and 18O-water 
purchased from Sigma and Olinax, Inc, respectively.37  
Cells and Viruses  
MDCK cells were purchased from the American Tissue Culture Collection (CCL-34) and 
grown in UltraMDCK serum-free medium (Lonza) that was supplemented with 104 units/mL 
penicillin G, and 10 mg/mL streptomycin. Influenza strain A/Aichi/2/68 (H3N2) was obtained from 
the American Tissue Culture Collection. Virus stocks were prepared by propagation of virus in 
MDCK cells under the aforementioned serum-free conditions including 2 µg/ml trypsin as 
previously described.27 Virus stocks were quantified by the 50% tissue culture infective dose 
(TCID50) in conjunction with the HA assay to determine infected wells27 and calculated by the 
method of Reed and Muench.38 
Metabolic Labeling and Virus Infection 
MDCK cells were cultured in UltraMDCK serum-free medium supplemented with penicillin G, 
streptomycin, 3 μM 15N-sphingolipid precursors at 37 °C in 5% CO2. Cell medium was aspirated 
and fresh medium containing 15N-sphingolipid precursors applied every day. On the third day, 
cells were passaged in serum-free growth medium supplemented with antibiotics, 3 μM 15N-
sphingolipid precursors, 215 μM 13C-fatty acids (4:1:28 mass ratio of UL-13C fatty acids/13C-stearic 
acid/fatty acid free bovine BSA), and 50 μM 18O-cholesterol (2:5 mass ratio of 18O-cholesterol:fatty 
acid-free BSA). The medium was aspirated and replaced with fresh medium containing 3 µM 15N-
sphingolipid precursors, 215 μM 13C-fatty acids, and 50 μM 18O-cholestrol every day.  On the sixth 
day, the cells were passaged into dishes that contained poly-L-lysine–coated silicon wafer chips 
33 
 
(5 x 5-mm). Some of these cells were chemically fixed in 4% glutaraldehyde and 1% osmium 
tetroxide as described below so they could be used to establish the lipid distribution in the plasma 
membranes of uninfected MDCK cells (referred to as control cells). On the 7th day, half of the 
remaining cells were inoculated with influenza virus (A/Aichi/2/68 strain) at MOI of 0.1 for 45 min 
to allow virus binding. For comparison, the other half of the metabolically labeled MDCK cells 
were mock-infected by adding identical medium that did not contain virus to their dishes (referred 
to as mock-infected cells). Once the virus and mock-infection inoculum was removed from their 
respective dishes, the cell medium was replaced with medium containing the aforementioned 
metabolic labels and 2 µg/ml trypsin. After 24 h, substrates were removed from the dishes and 
chemically fixed. For all experimental conditions (i.e., virus-infected, mock-infected, and 
uninfected controls), the cells that remained adhered to the dish were used to measure the 
incorporation of nitrogen-15 into sphingolipids and oxygen-18 into cholesterol by LC-MS and GC-
MS, respectively, as described.24,39 
Preparation of Cells for NanoSIMS Analysis 
The cells were chemically fixed as previously described.25 Briefly, chips were washed twice 
in DPBS (Dulbecco’s phosphate-buffered saline) to remove unbound virus and fixed with 2% 
paraformaldehyde and 0.05% glutaraldehyde in 0.1 M HPB for 25 min, washed three times in 
DPBS, and blocked in 1% BSA for 30 min. Following blocking, primary antibody at concentrations 
recommended by the manufacturer was placed on the chips for 30 min. Chips were washed 
extensively in DPBS with 1% BSA four times before the secondary antibody was added at 
concentrations recommended by the manufacturer for 30 min. Finally, chips were washed four 
times with 1% BSA in DPBS (first two washes) and HPB (last two washes). Following 
immunolabeling, the chips were preserved with 4% glutaraldehyde and 1% osmium tetroxide.24,39  
This chemical fixation does not alter the sphingolipid distribution in the cell membrane.24 To 
confirm that the cells were well-preserved and had normal morphologies, the chemically fixed 
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cells on the chips were imaged with a JEOL 7000F analytical scanning electron microscope at 1 
keV and 10 mm working distance.   
SIMS 
The fixed cell samples on the substrates were coated with 3 nm of iridium (99.95%) as 
previously described.40 The samples were analyzed using a Cameca NanoSIMS 50 instrument at 
Lawrence Livermore National Laboratory. The secondary electrons and the 16O−, 18O−, 12C14N−, 
12C15N−, and 32S- secondary ions were collected in parallel using a 0.17-pA, 16-keV 133Cs+ primary 
ion beam. Images of 15 × 15μm regions were compiled from 12 replicate scans of 512 × 512 
pixels that were acquired with a dwell time of 0.5 ms/pixel. Approximately the same 15 x 15-µm 
sample located was re-analyzed with a 1.137-pA, 16-keV 133Cs+ primary ion beam to image the 
gold immunolabels. The secondary electrons and 12C14N−, 32S-, 35Cl-, 197Au- secondary ions were 
collected in parallel. The images showing the 197Au- signals from the gold immunolabels were 
compiled using either 8 or 10 replicate scans (indicated) that were acquired with 512 x 512 pixels 
and a dwell time of 0.5 ms/pixel. 
Image Analysis 
To generate isotope enrichment images, LIMAGE software (L. R. Nittler, Carnegie Institution 
of Washington) run on the PV-Wave platform (Visual Numerics, Inc.) was utilized. The isotope 
enrichment is the 12C15N−/12C14N− or 18O-/16O- ratio divided by their terrestrial standard abundance 
ratio (0.00367 and 0.002005, respectively). The enrichment images showing 15N-sphingolipid and 
18O-cholesterol distributions were constructed using a 5 x 5 pixel moving average smoothing 
algorithm. A 3 x 3 pixel moving average smoothing algorithm was used for gold. Each analysis 
region overlapped with the preceding analysis region enabling manual positioning of each image 
to stitch together the resulting NanoSIMS images to form a mosaic of the cell. Because the 197Au- 
secondary ion and isotope enrichment images were acquired in two separate measurements, the 
197Au- secondary ion and isotope enrichment images were overlaid and manually aligned in order 
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to visualize the distributions of the gold immunolabels and the isotope-labeled lipids at the same 
locations on the cell. To do this, the secondary electron images that were acquired in parallel with 
the secondary ion images for each measurement were overlain and were used to manually align 
the corresponding gold and isotope enrichment images. After alignment, overlays of the isotope 
enrichment or gold images on the secondary electron images were created by using Adobe 
Photoshop to project the colors in the ion images onto the secondary electron images.     
The MATLAB Statistics Toolbox was used to identify the thresholds that denote statistically 
significant elevations in 15N-enrichment and 197Au- ion counts that identify 15N-sphingolipid-
enriched domains and immunogold clusters that represent the sites of influenza virus assembly 
and budding, respectively. The two-sample Kolmogorov-Smirnov test was also used to test for 
statistically significant differences between the 18O-enrichment in the 15N-sphingolipid domains 
and that in nondomain regions that were similar in size, as previously described.24 LIMAGE 
software was used to locate the regions of statistically significant elevations in 15N-enrichment 
and 197Au- counts that denote sphingolipid-enriched domains and sites of virus budding (termed 
Regions of Interest, ROI), respectively. The borders of these regions were outlined on the 
secondary electron images that were acquired in parallel with the secondary ions, and the image 
was exported from LIMAGE. To visualize the distributions of the gold immunolabels and the 
isotope-labeled lipids at the same locations on the cell, the secondary electron images with the 
15N-sphingolipid domains and 197Au- ROIs outlined were overlain, and manually aligned as 
described above. Then the numbers of 15N-sphingolipid domains that overlapped with 197Au- ROIs 
were manually counted to establish the percentage of 15N-sphingolipid domains co-localized with 
sites of influenza virus assembly and budding. 
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2.3. RESULTS 
Cholesterol and sphingolipid distributions in the plasma membranes of MDCK cells  
Because the lipid distributions in only one cell type, mouse fibroblast cells, had previously 
been characterized with high-resolution SIMS, the general distributions of sphingolipids and 
cholesterol in the plasma membranes of uninfected MDCK cells was first established. To enable 
the detection of the sphingolipids and cholesterol with high-resolution SIMS, the MDCK cells were 
cultured in serum-free medium that contained 15N-sphingolipid precursors and 18O-cholesterol. 
This resulted in the metabolic incorporation of the rare stable isotopes of nitrogen and oxygen, 
15N and 18O, respectively, into 51% of the cellular sphingolipids and 89% of the cholesterol on 
average. The cells were chemically fixed with a method that does not alter lipid distribution and 
analyzed with high-resolution SIMS. Figure 2.1B shows the secondary electron image that was 
acquired with a Cameca NanoSIMS 50 instrument of a metabolically labeled, uninfected, (control) 
MDCK, referred to as Control 1. No cracks are apparent on the cell body, which confirms that this 
cell was well-preserved. High-resolution SIMS was used to visualize the 15N-sphingolipid and 18O-
cholesterol distributions (Figure 2.1A and 2.1C, respectively) on the surface of the cell. To 
facilitate correlating the local lipid abundances with morphological features on the cell, Figures 
2.1D and 2.1E show the 15N-sphingolipid enrichment and 18O-cholesterol enrichment images 
overlain on the secondary electron image, respectively. The black regions within the 15N-
enrichment and 18O-enrichment images represent regions where the counts of these secondary 
ions were insufficient to calculate the isotope enrichment at this region on the cell. These regions 
are outlined with a white broken line in Figure 2.1A and 2.1C. These regions of insufficient counts 
occurred because the NanoSIMS instrument has a short working distance that reduces the 
efficiency of secondary ion collection on samples with high topography. Consequently, the 
rounding of the MDCK cells made them very challenging to analyze with high-resolution SIMS. 
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Sphingolipid domains are clearly present in the plasma membrane of this MDCK cell (Figure 
2.1A and Figure 2.1D). Our previous study confirmed that the 15N-enriched sphingolipid domains 
were not the result of cell surface topography, analyses by SIMS, sample fixation techniques, or 
due to the detection of intracellular membranes directly below the plasma membrane.24 For this 
cell, 15N-enrichments greater than 5.4 were found to be statistically significant and represent 15N-
sphingolipid-enriched domains. Local elevations in 18O-enrichment, which would signify the 
presence of cholesterol-enriched domains are not visible in Figure 2.1C. Instead, the cholesterol 
appears to be relatively uniform in distribution within the plasma membrane. Kolmogorov-Smirnov 
tests rejected the hypothesis that the 15N-sphingolipids domains were enriched with 18O-
cholesterol (p = 1.27 x 10-16, Table 2.1). This finding is consistent with the relatively homogenous 
18O-cholesterol distributions in the plasma membranes of Clone 15 cells and NIH 3T3 mouse 
fibroblast cells that have been previously described.24 This suggests that sphingolipid domains 
without increased cholesterol levels extrapolate across other species, possibly even human cell 
lines.  
Close examination of the overlay of the 15N-enrichment on the secondary electron images 
(Figures 2.1D) revealed some of the large 15N-sphingolipid-enriched patches were actually 
located at the interface between the cell and the substrate. These 15N-enriched patches appeared 
on and near the cell extensions in nearly all the MDCK cells we examined, regardless of virus 
exposure (vide infra). Based on the roundness of these 15N-sphingolipid patches, their locations 
on the cell extensions as well as the neighboring substrate, and their scarcity at regions of the 
substrate that were not adjacent to cells, it is tempting to speculate that they are sphingolipids 
that were secreted by the cells. However, further investigation is required to identify the precise 
composition and significance of the sphingolipid patches near the interface between the cell and 
its substrate. 
Similar lipid distributions were observed on the second whole, uninfected MDCK cell that was 
imaged (referred to as Control 2), as shown in Figure 2.2. Overlays of the 15N-sphingolipid 
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enrichment and 18O-cholesterol enrichment images on the secondary electron image are shown 
in Figures 2.2D and 2.2E, respectively.  Again, both isotope enrichment images (Figure 2.2A and 
Figure 2.2C) contain black regions where the isotope enrichment could not be measured due to 
the cell’s topography. Nonetheless, 15N-sphingolipid domains (Figure 2.2A) are evident in the 
plasma membrane. For this cell, 15N-enrichments greater than 6.9 are statistically significant and 
represent 15N-sphingolipid-enriched domains. Although the 18O-cholesterol appears uniform at 
most areas on the cell where the 18O-enrichments were measured, a region that is ~10 μm across 
near the top of Figure 2.2C appears to be cholesterol-enriched. While this region is not enriched 
with 15N-sphingolipids, inspection of the overlay of the 18O-enrichment image on the secondary 
electron images (Figures 2.2E) revealed this large 18O-enriched patch covered a relatively smooth 
region on the cell as well as the neighboring substrate. No such cholesterol-rich patches have 
been reported for mouse fibroblast cells.24,41 However, a few other MDCK cells exhibited similar 
patches of elevated 18O-cholesterol at smooth regions on their surfaces. The significance of these 
cholesterol-rich patches is not known at this time. Nonetheless, comparison of the 15N- and 18O-
enrichment images indicates the sphingolipid domains are not enriched with cholesterol.  
Consistent with this observation, the hypothesis that the 15N-sphingolipid domains are enriched 
with 18O-cholesterol was rejected by a Kolmogorov-Smirnov test (p = 1.10 x 10-22, Table 2.1).  
Assessment of cholesterol- and sphingolipid-enrichment at the site of influenza virus assembling 
and budding 
Our finding that that MDCK cells do not have plasma membrane domains that are enriched 
with cholesterol and sphingolipids suggests the influenza virus cannot exploit such domains for 
its assembly and budding. Yet, the influenza viral envelope is reported to have higher levels of 
cholesterol and sphingolipids than the host cell from which it buds.42 One possible explanation for 
these seemingly contradictory observations is that the influenza virus induces the formation of 
cholesterol- and sphingolipid-enriched plasma membrane domains and then uses these domains 
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to form its viral envelope. To test the hypothesis that the influenza virus assembles and buds from 
cholesterol- and sphingolipid-rich membrane domains, we combined metabolic lipid labeling with 
immunogold labeling of proteins to visualize the cholesterol, sphingolipids, and assembling 
influenza particles with high-resolution SIMS.  
We infected 15N-sphingolipid- and 18O-cholesterol-labeled MDCK cells with influenza virus at 
0.1 multiplicity of infection (MOI; infectious virus as determined by TCID50 per number of cells) 
over 24 h. These infection parameters maximize the percentage of cells infected while minimizing 
the cytopathic effect (CPE) seen in the general population of cells.43 This low MOI produced chips 
with high percentages of infected cells adhered to the substrate, ensuring the analysis of actual 
virus-infected cells during our limited time on the NanoSIMS instrument. In contrast, the infected 
cells rapidly detached from the substrates when infection was performed at higher MOI. Samples 
containing low fractions of virus-infected cells are not ideal given that cell analysis with high-
resolution SIMS analysis is time-consuming (~1/day) and costly. Following infection, cells were 
immunolabeled with anti-influenza virus primary antibodies followed by a gold-conjugated 
secondary antibody that detects primary anti-influenza virus antibody. Mock-infected control cells 
were immunolabeled following identical procedures as for the virus-infected cells.  
Figure 2.3A, 2.4A and 2.4D show the secondary electron images of regions on two different 
mock-infected cells, where the cell shown in Figure 2.3A is referred to as Mock-Infected Control 
1 and that shown in Figure 2.4A and 2.4D is referred to as Mock-infected Control 2. These 
secondary electron images show cell regions with no cracks and minimal rounding, implying 
proper fixation. Figure 2.3B, 2.4B, and 2.4E show the 15N-sphingolipid distribution on two mock-
infected control MDCK cells. 15N-enrichment factors greater than 4.5 for Figure 2.3B and 5.5 for 
both regions of the cell shown in Figure 2.4 are statistically significant elevations that represent 
15N-sphingolipid-enriched domains. These mock-infected cells appeared to have similar 15N-
sphingolipid domain features as the non-infected control cells, shown in Figures 2.1 and 2.2, on 
the cell body as well as domains found on and near the cell extensions. As shown in Figure 2.3C, 
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the 18O-cholesterol is elevated at a patch located at a central region on the cell body. In 
comparison, the 18O-cholesterol appears in fairly uniform distribution on the second mock-infected 
cell shown in Figure 2.4C and 2.4F. Figures 2.3E and 2.3F are 15N-sphingolipid enrichment and 
18O-cholesterol enrichment images overlain on the secondary electron images, respectively, with 
the distributions of detected gold depicted in green. Similar to the second uninfected MDCK cell, 
the 18O-cholesterol-rich patch that is visible in Figure 2.4C is located on a fairly smooth region on 
the cell, and it is not correlated with an elevated sphingolipid abundance. Indeed, analysis with 
Kolmogorov-Smirnov tests of the cells shown in Figure 2.3 and Figure 2.4 found that the 18O-
enrichment was not higher in the 15N-sphingolipid domains than the nondomain regions on the 
two mock-infected cells (Table 2.1). The similarity in the sphingolipid and cholesterol distributions 
found on these mock-infected cells and the uninfected, non-immunolabeled MDCK cells (Figures 
2.1 and 2.2) confirm that the immunolabeling did not alter the distributions of our labels. Sparse, 
non-specific gold was detected on the first mock-infected cell (Figure 2.3D-F), likely due to non-
specific binding of the antibody to the cell surface. Slightly more gold was detected in the image 
of the second mock-infected control cell (Figure 2.4G-L). However, no gold ROIs were detected 
on the body of the second mock-infected cell.  
Significantly more gold was detected on the virus-infected cells than the mock-infected cells, 
demonstrating the specificity of the immunogold labeling. Figure 2.5 shows one such virus-
infected cell (Virus-Infected 5) that was fixed at 24 h.p.i. Again, the 15N-sphingolipid- and 18O-
cholesterol-enrichment images (Figure 2.5B and 2.5C, respectively) contain regions where the 
enrichments could not be measured due to high topography (outlined with white dotted lines). In 
Figure 2.5, 15N-enrichments greater than 5.5 are statistically significant elevations that represent 
15N-sphingolipid-enriched domains. Analysis with Kolmogorov-Smirnov tests rejected the 
hypothesis that the 18O-enrichment was higher in 15N-sphingolipid domains than the nondomain 
regions on this cell. Green-labeled gold regions signifying immunolabeled budding virus are 
shown in Figure 2.5D and the overlays (Figure 2.5E-F) of the 15N-sphingolipid and 18O-cholesterol 
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images on the secondary electron image. Many budding virus regions were detected on the cell 
body and cell extensions with few, if any, were detected on the substrate. As shown by the arrow, 
most of the budding virus that appears to be adjacent to the cell was actually detected on the cell 
extensions. This is evidence that the antibodies did in fact bind budding influenza virus and did 
not non-specifically bind to the substrate. The gold detected at the substrate surface could 
indicate the presence of a small amount of progeny virus particles that had completed the budding 
process and were not removed from the substrate by washing.  
Visual inspection of Figure 2.5E shows the green-labeled gold, signifying the assembling and 
budding virus, does not correlate with the 15N-sphingolipid domains on the cell. To confirm this, 
the number of 15N-sphingolipid domains that overlapped with the signal from the gold-labeled 
virus (Figure 2.6) were manually counted (see Materials and Methods section for details). We 
found that approximately 2% of all sphingolipid domains contained virus (map showing each 15N-
sphingolipid domain and gold ROI shown in Figure 2.6). This directly refutes the hypothesis that 
the influenza virus assembles and buds from sphingolipid- and cholesterol-enriched regions in 
the plasma membrane.16,44,45  
Noteworthy, control experiments indicated that the vast majority of the immunolabeled virus 
was in the process of assembling and budding, as opposed to entering the cell. In these 
experiments, cells were infected at high (10) MOI and infection was allowed to proceed for only 
15 min prior to washing and fixation to maximize the amount of virus that could potentially attach 
to the cell. For comparison, cells were also prepared using the same infection and incubation 
conditions as those used for high-resolution SIMS. The immunogold-labeled virus particles on the 
cell surface were detected with scanning electron microscopy (SEM) using backscatter detection 
mode and revealed very few bright spots signifying gold-labeled virus particles (<10) on entire 
surfaces of each whole cell (Figure 2.7). The absence of these bright particles in the standard 
secondary electron emission images confirms that these bright spots are gold (Figures 2.7B, D, 
and F). In comparison, drastically more gold particles were detected on cells that were subjected 
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to 24 h of virus infection in parallel to the samples that were analyzed by high-resolution SIMS 
(Figure 2.7A). Thus, the vast majority of the immunogold labels detected with the high-resolution 
SIMS was budding virus, with negligible contributions from entering virus.  
Figure 2.8 shows a region on another virus-infected, isotope-labeled MDCK cell (Virus-
Infected 2). Figure 2.8A shows the secondary electron image. Figure 2.8B shows the 15N-
sphingolipid distribution, with 15N-enrichments greater than 5.7 being statistically significant 
elevations that represent 15N-sphingolipid domains, and Figure 2.8C shows the 18O-cholesterol 
distribution. A Kolmogorov-Smirnov test confirmed that the 18O-enrichment was not higher in 15N-
sphingolipid domain regions compared to nondomain regions (p = 1.89 x 10-5, Table 2.1). Figures 
2.8E and 2.8F are 15N-sphingolipid enrichment and 18O-cholesterol enrichment images overlain 
on the secondary electron images, respectively, with the distributions of detected gold depicted 
in green. In this image, many green regions that denote immunolabeled budding virus are clearly 
visible on the cell extensions. Many large clusters of virus proteins are present, which are 
consistent with the presence of active influenza budding zones on the surface of the cell.15,45 
Figure 2.9 shows the locations of the 15N-sphingolipid domains in relation to the gold ROIs. Based 
on analysis of this image, approximately 13% of the 15N-sphingolipid domains overlapped with the 
budding virus, which is the highest percentage detected on any virus-infected cells that were 
analyzed.  
Figure 2.10A, 2.10B, 2.10C, and 2.10D show the secondary electron image, 15N-sphingolipid 
distribution, 18O-cholesterol distribution, and immunogold-labeled influenza virus, respectively, at 
a region on another virus-infected, isotope-labeled MDCK cell (Virus-Infected 1). 15N-enrichment 
factors greater than 4.5 were found to be statistically significant elevations that represent 15N-
sphingolipid-enriched domains. Unlike the other cells, a Kolmogorov-Smirnov test failed to reject 
the hypothesis that the 18O-enrichment was higher in 15N-sphingolipid domains than the 
nondomain regions (p = 1, Table 2.1). Again, immunogold-labeled virus was detected on the small 
extensions of the cell (arrow). Figures 2.10E and 2.10F show the 197Au- ion intensities (green) 
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and either the 15N-sphingolipid or 18O-cholesterol enrichments (thermal false color scale), 
respectively, overlain on the secondary electron images. Only approximately 11% of 15N-
sphingolipid domains overlapped with the virus (Figure 2.11).  
Similar distributions of 15N-sphingolipids, 18O-cholesterol, and immunogold-labeled budding 
influenza virus were observed on the surfaces of two other virus-infected MDCK that were also 
imaged with SIMS (Figure 2.12 and 2.14, referred to as Virus-Infected 3 and 4, respectively).  As 
with the other virus-infected cells we analyzed, little overlap between the 15N-sphingolipid domains 
and the budding virus was observed (Figure 2.13 and 2.15). A Kolmogorov-Smirnov test indicated 
the 18O-enrichment was higher in 15N-sphingolipid domains than the nondomain regions on the 
virus-infected cell shown in Figure 2.12 (p = 0.99, Table 2.1), but not on the cell shown in Figure 
2.14 (p = 7.70 x 10-5, Table 2.1).  The total number of gold ROIs that locate the budding virus as 
well as the percentages of sphingolipid domains colocalized with gold ROI detected for each virus-
infected and mock-infected cell are summarized in Table 2.2. Overall, colocalization between the 
15N-sphingolipid domains and immunogold-labeled influenza virus ranged from 0.3-12.7%.   
2.4. DISCUSSION 
We have shown that both uninfected and virus-infected MDCK cells have sphingolipid-
enriched domains, but the domains on the uninfected cells and three of the five infected MDCK 
cells do not contain higher cholesterol abundance as compared to nondomain regions. This is 
consistent with findings in other cell types.24 Because our reports have found that traditionally 
defined lipid rafts do not exist in the cells that we have analyzed thus far,24,41 the evidence for the 
enrichment of the influenza virus envelope with cholesterol and sphingolipids is peculiar, 
especially now that we have definitively shown that this virus does not bud from sphingolipid-
enriched regions. As described earlier, previous methods do not provide a direct link between the 
influenza virus bud zones and the lipid profile of the plasma membrane from which the virus buds. 
Not only have previous NanoSIMS analyses demonstrated that the HA envelope protein alone 
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does not selectively partition into sphingolipid-enriched domains,41 but now we see that the 
presence of all  influenza virus components during infection also does not produce budding virus 
that favors sphingolipid-enriched domains. Previous attempts to determine the lipid compositions 
of partially intact apical membranes for comparison to the influenza virus envelope employed a 
peeling protocol to isolate the apical membrane from whole cells.42 In this method, contact with a 
surface results in the adherence of the apical membrane that allows it to be ripped from the cells, 
presumably severing its contact with underlying structures such as intracellular organelles and 
the basolateral surface of the plasma membrane.46 While specific markers of contamination from 
some obvious underlying cell features, such as the basolateral plasma membrane, are used to 
verify the isolation of the apical membrane,42,46 rigorous testing for contamination from sub-
plasma membrane regions is lacking. Indeed, examination by SEM and transmission electron 
microscopy (TEM) has revealed that a thin layer of cytoplasm accompanies the apical membrane 
when it is ripped from the cell.47 The presence of intracellular vesicles or small fragments of other 
intracellular membranes in this layer of cytoplasm could easily skew the lipid composition of the 
peel, making its comparison to the lipids in the influenza virus envelope inaccurate. This leads to 
questions regarding the true lipid profile of the donor plasma membrane. The results we show 
here are a clear divergence from the multitude of previous studies implying the opposite, and truly 
highlights the need for a method to study lipids in situ that does not alter their native distributions. 
Imaging the native distributions of lipids is imperative to understanding true relationships. 
In total, we were able to image the 15N-sphingolipid, 18O-cholesterol, and 197Au-labeled 
influenza virus distributions on three whole cells and regions on two additional cells. Table 2.1 
provides a summary of the Kolmogorov-Smirnov test results for each cell that was analyzed. Of 
these cells, two had statistically significant elevations in 18O-cholesterol levels within their 15N-
sphingolipid domains. These two cells include one whole cell (Figure 2.12) and one partial cells 
(shown in Figure 2.10). Of the five total virus-infected cells that were analyzed, the Kolmogorov-
Smirnov test indicated the distributions of 18O-enrichments measured in the sphingolipid domains 
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were statistically different from the nondomain regions in two cells (Figure 2.14, a whole cell; 
Figure 2.8, a partial cell), but the 18O-enrichment was not statistically higher in 15N-sphingolipid 
domain regions compared to nondomain regions. Only one virus-infected cell was found to have 
no statistical differences between the 18O-enrichment in the domains and nondomains (Figure 
2.5). Although not all of the virus-infected cells showed elevated 18O-cholesterol within their 15N-
sphingolipid domains, we cannot ignore the possibility that the influenza virus induced these 
cholesterol enrichments. In all of our previously published studies of a variety of healthy, 
uninfected cells, including the non-infected control MDCK cells (Figures 2.1 and 2.2) and mock-
infected MDCK cells (Figures 2.3 and 2.4) we show here, we have not found reproducible 
elevations in 18O-cholesterol enrichment within the 15N-sphingolipid domains.24,41 Yet, now we find 
two of the five, which is nearly half of the infected cells that we analyzed, had sphingolipid domains 
that were enriched with cholesterol. These differences are intriguing and we can only surmise 
why they might arise. Because each cell could have been infected at any time during the 24 h 
infection period, we theorize that each cell was likely infected for different lengths of time prior to 
fixation. Longer infection times may allow the influenza virus to shift the subcellular distributions 
of cholesterol or other lipids, whether through altering native membrane trafficking or intracellular 
lipid abundance by manipulating de novo synthesis or uptake, to favor the replication and 
packaging of future progeny virus. This interesting finding brings up new questions regarding the 
role of lipids in influenza virus replication and how the influenza virus could be manipulating them 
to induce favorable replication conditions within the cell. Perhaps the finding of cholesterol-
enriched sphingolipid domains in some infected cells is not due to viral manipulation of these 
lipids to produce favorable regions from which to bud from, but a by-product of lipid dysregulation 
that the virus induces for another purpose. Evidence of lipid dysregulation induced by the 
influenza virus has been shown in previous reports. Influenza selectively increases the levels of 
sphingolipids in host cells, and decreases others, such as phosphatidylethanolamine, and 
infection results in increased sphingolipid levels in the influenza virus envelope compared to host 
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whole cell extracts.48 This implies the influenza virus favors sphingolipids for some reason, 
however, our data clearly indicates it is not due to viral targeting of sphingolipid-enriched regions 
at the plasma membrane for use as the site of budding.  
Of high importance, however, even in the virus-infected cells that were found to have 
statistically significant elevations in the 18O-cholesterol levels within the sphingolipid domains as 
compared to the nondomain membrane regions, the influenza virus was overwhelmingly found in 
membrane domains that were not enriched with sphingolipids or cholesterol. This strongly implies 
the influenza virus is not targeting cholesterol- and sphingolipid-enriched regions at the plasma 
membrane for assembly and budding. Influenza’s intricate relationship with cholesterol and 
sphingolipid levels within the cell may be partially explained by the dependence of proper viral 
protein transport on these lipids. Notably, a link has been found between the transport of influenza 
HA and sphingomyelin, a type of sphingolipid.49 When the cell’s ability to produce sphingomyelin 
was inhibited, a marked decrease in HA transport from the Golgi apparatus to the cell surface 
was detected.49 A relationship between the virus or influenza components with cholesterol has 
been known for some time and has usually been attributed to the hypothesis that the virus buds 
from lipid rafts.16,50,51 Viperon, an interferon-induced host defense mechanism, has been shown 
to reduce the activity of farnesyl diphosphate synthase (FPPS), an enzyme involved in isoprenoid 
biosynthesis, and inhibits the release of influenza from the plasma membrane.52 Others have used 
cyclodextrins or other drugs that manipulate cholesterol metabolism to demonstrate influenza’s 
dependence on cholesterol;50,53 these, however, cause many unintentional consequences making 
data interpretation challenging.54,55 Recently, a report was published correlating the transport of 
the influenza virus genome with cholesterol-enriched recycling endosomes.56 The virus was found 
to induce cholesterol accumulation at these sites, with hindrance of such accumulation correlated 
to disrupted bud site formations.56 This report may partially explain influenza’s dependence on 
host cholesterol in light of our finding that this virus does not exploit cholesterol-enriched domains 
for assembly and budding. 
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The challenges of studying lipids in their native context have been highlighted here. The 
influenza virus was long thought to exploit sphingolipid- and cholesterol-enriched regions at the 
plasma membrane and our attempts to validate this hypothesis has led to major advancements 
in the field of SIMS bioimaging. Now, we are able to image sphingolipids, cholesterol, and budding 
virus at the same sites in the plasma membranes of intact cells at resolutions that have never 
been attained prior. Understanding the natural distributions of lipids within whole healthy cells 
compared to diseased cells could highlight where viral-induced changes are occurring. The 
imaging of the 3-dimensional distributions of lipids in whole cells using high-resolution SIMS has 
very recently been realized,40 elucidating the intricate internal network of sphingolipids and 
cholesterol. Further studies to determine intracellular membrane lipid compositions will provide 
detailed understandings of the host cell and the lipid pools the influenza virus exploits.   
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2.6. FIGURES AND TABLES  
 
 
Figure 2.1 High-resolution SIMS mosaic images of a metabolically labeled MDCK cell that were 
constructed from individual SIMS images acquired at 15 µm x 15 µm regions. White dotted lines 
signify regions in which enrichment measurements were not acquired due to the high topography 
of the sample surface. Denoted as Control 1 in Table 2.1. A) The mosaic image showing the 
distribution of metabolically incorporated 15N-sphingolipids in the plasma membrane of the MDCK 
cell. 15N-enrichment factors greater than 5.4 were found to be statistically significant elevations 
that represent 15N-sphingolipid-enriched domains, represented by red, orange, and yellow 
regions. B) The mosaic secondary electron image composed of images taken in parallel with the 
isotope images shows the topography of the cell. C) The mosaic image showing the relatively 
even distribution of metabolically incorporated 18O-cholesterol in the plasma membrane of the 
MDCK cell. D) The 15N-enrichment mosaic image was overlain on the mosaic of secondary 
electron images, taken in parallel, of the MDCK cell. E) The 18O-enrichment mosaic image was 
overlain on the secondary electron image, taken in parallel, of the MDCK cell. 
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Figure 2.2 High-resolution SIMS mosaic images of a metabolically labeled MDCK cell showing 
large 15N-sphingolipid domains present at the boundaries of the cell, possibly on the numerous 
cell extensions that are present. White dotted lines signify regions in which enrichment 
measurements were not acquired due to the high topography of the sample surface. Denoted as 
Control 2 in Table 2.1. A) The 15N-sphingolipd distribution in the plasma membrane of the cell. 
15N-enrichment factors greater than 6.9 were found to be statistically significant elevations that 
signify 15N-sphingolipid-enriched domains, represented as red, orange, and yellow. B) The 
secondary electron mosaic image of the MDCK cell. C) The relatively even distribution of 
metabolically incorporated 18O-cholesterol in the plasma membrane of the cell. D) The 15N-
enrichment mosaic image was overlain on the secondary electron mosaic image that was 
acquired in parallel. E) The 18O-enrichment mosaic image overlain on the secondary electron 
mosaic image that was acquired in parallel.  
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Figure 2.3 Mosaic images of adjacent regions on the same mock-infected MDCK cell shows the 
low non-specific binding of the antibodies. Denoted as Mock-Infected Control 1 in Table 2.1. A) 
The secondary electron mosaic of the mock-infected cell shows most of the plasma membrane. 
B) The 15N-sphingolipid distribution of the mock-infected cell shows 15N-sphingolipid domains, 
represented by red, orange, and yellow. 15N-enrichment factors greater than 4.5 were found to be 
statistically significant elevations that represent 15N-sphingolipid-enriched domains. C) The 18O-
cholesterol distribution of the mock-infected cell shows relatively even cholesterol distribution in 
most of the plasma membrane, though the center region in the lower set of images appears to be 
cholesterol-enriched. D) The gold counts detected on the mock-infected cell images show low 
non-specific binding of the antibodies. As shown, very low gold counts were found on the mock-
infected control cell. Gold images are comprised of 10 replicate analysis planes. E) Overlay of the 
15N-enrichment and 197Au- images on the secondary electron images shows the distributions of 
15N-sphingolipids and anti-flu immunogold (represented by green) with respect to cell morphology. 
F) Overlay of the 18O-enrichment and 197Au- images on the secondary electron images show the 
distributions of 18O-cholesterol and anti-flu immunogold (represented by green) on the cell.   
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Figure 2.4 Images of a 
mock-infected MDCK 
cell. The isotope-
secondary electron-
gold overlays were 
made by manual 
alignment of the 
secondary electron 
images from the 
separate acquisitions 
of the isotope images 
and gold images. 
Denoted as Mock-
Infected Control 2 in 
Table 2.1. A, D) The 
secondary electron 
images of a mock-
infected cell acquired at 
two separate regions 
on the cell. B, E) The 
15N-sphingolipid 
distribution of the 
mock-infected cell 
shows 15N-sphingolipid 
domains, represented 
by red, orange, and 
yellow. 15N-enrichment 
factors greater than 5.5 
were found to be 
statistically significant 
elevations that 
represent 15N-
sphingolipid-enriched domains. C, F) The 18O-cholesterol distribution of the mock-infected cell 
shows a relatively even cholesterol distribution in the plasma membrane. G, J) The gold counts 
detected. Gold images are comprised of 10 replicate analysis planes. No statistically significant 
elevations in gold counts were found on the cell body. H, K) Overlay of the 15N-enrichment and 
197Au- images on the secondary electron images shows the distributions of 15N-sphingolipids and 
anti-flu immunogold (represented by green) on the cell. I, L) Overlay images show the distributions 
of 18O-cholesterol and anti-flu immunogold (represented by green) on the cell.  
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Figure 2.5 Infection of a metabolically labeled 
MDCK cell shows the virus distribution at 24 h.p.i. 
The virus was primarily found in regions devoid of 
sphingolipid domains. White dotted lines signify 
regions where enrichment measurements were not 
acquired due to the high surface topography. 
Denoted as Virus-Infected 5 in Table 2.1. A) The 
mosaic secondary electron image of the infected 
cell. B) The 15N-sphingolipid distribution. 15N-
enrichment factors greater than 5.5 were found to be 
statistically significant elevations that represent 15N-
sphingolipid-enriched domains (represented by red, 
orange, and yellow). C) The 18O-cholesterol 
distribution on the infected cell. This cell was found 
to have relatively even cholesterol distribution. D) 
The gold counts that locate the budding virus were 
found on the cell body and cell extensions. Gold 
images are comprised of 10 replicate analysis 
planes. E) Overlay mosaic image showing the 
distributions of 15N-sphingolipids and gold-labeled 
influenza virus on the cell. Many budding virus 
particles were located on the cell extensions 
(arrows). F) Overlay mosaic image showing the 
distribution of 18O-cholesterol and the gold-labeled 
influenza virus on the cell. 
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Figure 2.6 Relative distribution of each 15N-sphingolipid domain (black) and gold ROI (green) that 
locates budding virus for the sample referred to as Virus-Infected  5 (shown in Figure 2.5). 
Approximately 2.3% of all 15N-sphingolipid domains overlapped with gold ROI. 
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Figure 2.7 
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Figure 2.7 (cont.) A comparison of cells infected for 24 h at 0.1 MOI and 15 min at 10 MOI to gauge whether influenza virus bound to 
the cell surface, but not yet internalized, could be detected using the backscatter detection mode during SEM analysis. Elements with 
high atomic number, such as gold, appear brighter than elements of low atomic number. This allows the immunogold label to be 
detected as bright round spots on the cell surface. A stark contrast is evident as cells exposed to virus for 24 h have exponentially 
more gold particles detected at the cell surface, establishing that the washings conducted prior to cell fixation are adequate to remove 
any surface-bound virus that is not in the final stages of budding. A) Backscatter detection of gold particles on a metabolically labeled 
MDCK cell 24 h.p.i. Many hundreds of gold particles are present on the cell plasma membrane. A few of these are denoted by the 
arrows. B) SEM of the same region shown in A. C) Backscatter detection of gold particles on a metabolically labeled MDCK cell 15 min 
post infection. No gold particles were observed on this region of cell body. D) SEM of the same region shown in C. E) Backscatter 
detection of gold particles on a metabolically labeled MDCK cell 15 min post infection. One gold particle is denoted by the arrow. F) 
SEM of the same region shown in E.  
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Figure 2.8 Virus infection of a metabolically labeled MDCK cell shows the influenza virus 
distribution at the plasma membrane 24 h.p.i. Denoted as Virus-Infected 2 in Table 2.1. A) The 
secondary electron image of the infected cell. B) The 15N-sphingolipid distribution of an infected 
cell shows sphingolipid domains are present, represented by red, orange, and yellow. 15N-
enrichment factors greater than 5.7 were found to be statistically significant elevations that 
represent 15N-sphingolipid-enriched domains. C) The 18O-cholesterol distribution of an infected 
cell. This cell was found to have relatively even cholesterol distribution, with similar cholesterol 
enrichment found in the sphingolipid domain and nondomain regions. D) The gold counts that 
locate the budding influenza virus were found on the plasma membrane of the cell body and the 
cell extensions. Gold images are comprised of 10 replicate analysis planes. E) Overlay image 
showing the 15N-sphingolipid distribution, the secondary electron image, and the gold-labeled 
influenza virus. F) Overlay image showing the 18O-cholesterol distribution, the secondary electron 
image, and the gold-labeled influenza virus.  
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Figure 2.9 Relative distribution of each 15N-sphingolipid domain (black) and gold ROI (green) for 
Virus-Infected 2 (shown in Figure 2.8). Approximately 12.7% of all 15N-sphingolipid domains had 
overlap with the gold ROI that locates the budding virus. 
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Figure 2.10 Virus infection of a metabolically labeled MDCK cell shows the influenza virus 
distribution at the plasma membrane 24 h.p.i. Denoted as Virus-Infected 1 in Table 2.1. A) The 
secondary electron image of a region of the infected cell. B) The 15N-sphingolipid distribution of 
an infected cell shows sphingolipid domains are present, represented by red, orange, and yellow. 
15N-enrichment factors greater than 4.5 were found to be statistically significant elevations that 
represent 15N-sphingolipid-enriched domains. C) The 18O-cholesterol distribution. This cell was 
found to have higher 18O-enrichment within the domain regions compared to nondomain regions. 
D) The gold counts that locate the budding influenza virus were found on the plasma membrane 
of the cell body and the cell extensions (arrow in E). Gold images are comprised of 10 replicate 
analysis planes. E) Overlay image showing the 15N-sphingolipid distribution, the secondary 
electron image, and the gold-labeled influenza virus. F) Overlay image showing the 18O-
cholesterol distribution, the secondary electron image, and the gold-labeled influenza virus. 
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Figure 2.11 Relative distribution of each 15N-sphingolipid domain (black) and gold ROI (green) 
that locates budding virus for Virus-Infected 1 (shown in Figure 2.10). Approximately 10.9% of all 
15N-sphingolipid domains overlapped with the gold ROI.  
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Figure 2.12 Virus infection of a metabolically labeled MDCK cell shows the influenza virus 
distribution at the plasma membrane 24 h.p.i. The influenza virus was primarily found in regions 
that were not enriched with sphingolipids. Denoted as Virus-Infected 3 in Table 2.1. A) The mosaic 
secondary electron image of the infected cell. B) The 15N-sphingolipid distribution of an infected 
cell shows sphingolipid domains are present. 15N-enrichment factors greater than 7.7 were found 
to be statistically significant elevations and they signify 15N-sphingolipid-enriched domains. These 
are represented by red, orange, and yellow. C) The 18O-cholesterol distribution of the infected 
cell. This cell was found to have increased 18O-enrichment within the sphingolipid domains on the 
cell body as compared to the nondomain regions. D) The gold counts that locate the budding 
influenza virus were found on the plasma membrane of the cell body and cell extensions. Gold 
images are comprised of 8 replicate analysis planes. E) Mosaic image showing the overlay of the 
15N-sphingolipid distribution, the secondary electron images, and the gold-labeled influenza virus. 
The influenza virus was primarily found in regions of the cell membrane that lacked sphingolipid 
domains. F) Mosaic image showing the overlay of the 18O-cholesterol distribution, the secondary 
electron images, and the gold-labeled influenza virus. 
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Figure 2.13 Relative distribution of each 15N-sphingolipid domain (black) and gold ROI (green) 
for Virus-Infected 3 (shown in Figure 2.12). Approximately 3.8% of all 15N-sphingolipid domains 
overlapped with gold ROI that locate the sites of influenza virus assembly and budding. 
 
 
 
67 
 
 
Figure 2.14 Influenza virus infection of a metabolically labeled MDCK cell 24 h.p.i. Denoted as 
Virus-Infected 4 in Table 2.1. A) The mosaic secondary electron image of the infected cell. B) The 
15N-sphingolipid distribution of the infected cell shows sphingolipid domains are present, 
represented by red, orange, and yellow. 15N-enrichment factors greater than 5.2 were found to be 
statistically significant and represent 15N-sphingolipid-enriched domains. C) The 18O-cholesterol 
distribution on the infected cell. This cell had a relatively even 18O-cholesterol enrichment within 
the sphingolipid domains and nondomain regions on the cell body. D) The gold counts that locate 
the budding influenza virus. Gold images are comprised of 10 replicate analysis planes. E) Mosaic 
image showing the overlay of the 15N-sphingolipid distribution, the secondary electron images, 
and the gold-labeled influenza virus. The influenza virus was primarily found in regions on the cell 
membrane that lacked sphingolipid domains. F) Mosaic image showing the overlay of the 18O-
cholesterol distribution, the secondary electron images, and the gold-labeled influenza virus. 
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Figure 2.15 Relative distribution of each 15N-sphingolipid domain (black) and gold ROI (green) 
for Virus-Infected 4 (shown in Figure 2.14). Approximately 0.3% of all 15N-sphingolipid domains 
had overlapping gold.
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Table 2.1 Summary of the statistical analysis assessing whether the 18O-cholesterol enrichment in sphingolipid domain regions is 
greater than in nondomain regions. P-values < 0.05 mean reject the hypothesis at the 95% confidence interval. 
 
 
 
 
 
 
 
 
 
 
 
Domains Nondomains
Control 1 5.1 ± 6.5 4.9 ± 4.2 
Control 2 4.3 ± 4.7 4.4 ± 3.4
Mock-Infected Control 1 9.2 ± 8.6 7.1 ± 5.4 
Mock-Infected Control 2 8.0 ± 9.1 6.0 ± 5.4 
Virus-Infected 1 11.2 ± 10.4 6.1 ± 6.8 
Virus-Infected 2 6.9 ± 9.7 6.8 ± 6.6 
Virus-Infected 3 7.8 ± 8.2 5.7 ± 6.6 
Virus-Infected 4 8.3 ± 12.3 6.5 ± 6.9 
Virus-Infected 5 7.6 ± 9.2 6.7 ± 5.1 
p value, Kolmogorov-
Smirnov test that 18O-
enrichment in domains is 
higher than nondomains
Reject hypothesis that 18O-enrichment 
in the domains is higher than 
nondomains (at 95% CI)?
Yes
No 
Yes
Yes
No 
Yes
Yes
Yes
0.45
1.94 x 10-25
3.78 x 10-5
9.66 x 10-5
1.54 x 10-4
0.24 N/A
5.35 x 10-5
Yes
N/A
1.27 x 10-16
1.10 x 10-22
0.0317
N/A
1
1.89 x 10-5
0.99
7.70 x 10-5
2.54 x 10-16
2.20 x 10-22
Cell
18O-enrichment, µ ± 1 s.d.
p value, Kolmogorov-
Smirnov test that 18O-
enrichment in domains and 
nondomains are the same
Reject hypothesis that 18O-
enrichment in the domains 
and nondomains are the 
same (at 95% CI)?
No, 18O-enrichment is higher in domains
YesYes
Yes
Yes
N/A
No, 18O-enrichment is higher in domains
Yes
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Table 2.2 Summary of the total number of gold Regions of Interest (ROIs) found and percentage of 15N-sphingolipid domains with 
overlapping gold for each cell. See Material and Methods for details on ROI analysis. *Note that cell had 3 images of gold ion acquired 
but 4 total isotope images acquired. 
 
 
 
 
 
 
 
 
 
 
Mock-Infected Control 1 4 1
Mock-Infected Control 2 2 16
Virus-Infected 1 2 357
Virus-Infected 2 1 79
Virus-Infected 3 3* 158
Virus-Infected 4 4 357
Virus-Infected 5 5 307
Cell Total Number of Gold ROIs
0
2.3
Number of Images Acquired 
During Acquisition of Gold
0
10.9
12.7
3.8
0.3
Percent of 15N-Enriched Domains 
with Overlapping Gold ROI
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CHAPTER 3. 
THREE-DIMENSIONAL IMAGING OF CHOLESTEROL AND SPHINGOLIPIDS WITHIN A 
MADIN-DARBY CANINE KIDNEY CELL 
3.1. INTRODUCTION2 
Lipids and cholesterol comprise cellular membranes and also play important roles in signal 
transduction1,2 and intracellular trafficking.3,4 Alterations in the distributions of various lipid species 
within subcellular compartments are linked to a variety of pathologies, the most well-known being 
Niemann-Pick disease.5 Direct imaging of the lipid and cholesterol compositions of various 
subcellular compartments without the use of fluorophores that may alter organization and 
intracellular trafficking6 would provide a valuable alternative perspective on native cell structure, 
and ultimately, function. Furthermore, three-dimensional imaging would enable organelles and 
intracellular processes to be resolved. 
We previously used high-resolution secondary ion mass spectrometry (SIMS), which we 
performed with a Cameca NanoSIMS 50, to image the distributions of cholesterol and 
sphingolipids on the surfaces of fibroblast cells.7-9 For analyses performed on this instrument, a  
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focused cesium or oxygen primary ion beam is scanned over the sample. Monoatomic and 
diatomic secondary ions with up to five different mass-to-charge ratios (m/z) are collected in 
parallel at every pixel, producing images of the elemental or isotopic composition at the surface 
of the sample with a lateral resolution as good as 50 nm.10,11 In our approach, distinct stable 
isotopes that encode for component identity are selectively incorporated into the lipid species of 
interest with established metabolic labeling techniques.12 Then the component-specific isotope 
enrichment in the membrane cell is imaged with approximately 90 nm lateral resolution with a 
Cameca NanoSIMS 50 instrument. Use of this approach to visualize metabolically incorporated 
18O-cholesterol and 15N-sphingolipids on the surfaces of fibroblast cells revealed the plasma 
membrane contained a fairly uniform cholesterol distribution and micrometer-scale 15N-
sphingolipid patches.7 By imaging the effects of drugs on the sphingolipid distribution, we 
determined the sphingolipids were confined within domains by the cytoskeleton and its associated 
proteins.7,8  
Having identified the cholesterol and sphingolipid distribution within the plasma membrane, 
we have now turned our focus to investigating their intracellular distributions, including their 
abundances within intracellular membranes. The compositions of intracellular membranes have 
been previously assessed by lysing populations of cells, separating the organelles with 
centrifugation, and then analyzing the lipid composition in each fraction by biochemical assays or 
liquid chromatography-mass spectrometry (LC-MS).13,14 A pitfall of this approach is that the 
measured cholesterol levels depend on the method used to fractionate the cells, likely due to 
contamination with membranes from other organelles and spontaneous cholesterol transfer 
between membranes after cell disruption.15  SIMS is an attractive alternative approach for probing 
the distributions of lipids and metabolites within intact cells. A thin layer of material is sputtered 
from the sample each time the primary ion beam interrogates its surface, allowing a series of 
images to be acquired at progressively increasing depth below the cell surface by successively 
re-imaging the same location multiple times. Sputtering scans that remove more material from the 
73 
 
sample’s surface are often inserted between the imaging scans to reduce the analysis time 
required to depth profile through the cells.16,17 Both NanoSIMS instruments and new time-of-flight 
SIMS (ToF-SIMS) instruments that do not need distinct labels for component identification have 
been used to image the intracellular distributions of nucleotides, lipids, amino acids, 
nanoparticles, and elements of interest.18-24 However, the intracellular distributions of cholesterol 
and sphingolipids have not been imaged in parallel and with sub-micrometer lateral resolution. 
As a first step towards assessing the abundances of sphingolipids and cholesterol within the 
membranes of distinct organelles, here we use high-resolution SIMS, performed with a Cameca 
NanoSIMS 50, to directly image the cholesterol and sphingolipid distribution within a portion of a 
Madin-Darby Canine Kidney (MDCK) cell.  
3.2. MATERIALS AND METHODS 
Materials  
MDCK cells were obtained from ATCC (CCL-34) and adapted over multiple passages to grow 
in UltraMDCK serum-free medium (Lonza) supplemented with 104 units/mL penicillin G, and 10 
mg/mL streptomycin. Fatty acid-free bovine serum albumin (BSA), 13C18-stearic acid (99 atom% 
carbon-13), and other cell culture materials were obtained from Sigma. Poly-L-lysine and 
chemical preservation reagents were obtained from Electron Microscopy Sciences. Silicon wafer 
chips were obtained from Ted Pella Inc. Uniformly carbon-13 labeled (98 atom%) fatty acids were 
obtained from Cambridge Isotope Laboratories. Reported methods were used to synthesize the 
15N-sphingolipid precursors, 15N-sphingosine and 15N-sphinganine from 15N-serine (Cambridge 
Isotope Laboratories).25-27 18O-Cholesterol was synthesized from i-cholesteryl methyl ether 
(Sigma) and 18O-water (Olinax, Inc.) as reported.28  
Metabolic Labeling 
MDCK cells were cultured in UltraMDCK serum-free medium supplemented with 3 μM 15N-
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sphingolipid precursors at 37 °C in 5% CO2. Each subsequent day, cell medium was aspirated 
and fresh applied with added 15N-sphingolipid precursors. On day 3, cells were passaged in 
serum-free growth medium supplemented with 3 μM 15N-sphingolipid precursors, 215 μM 13C-
fatty acids (4:1:28 mass ratio of UL-13C fatty acids/13C-stearic acid/fatty acid free bovine BSA), 
and 50 μM 18O-cholesterol (2:5 mass ratio of 18O-cholesterol:fatty acid-free BSA). Each 
subsequent day, the medium was aspirated and replaced with fresh medium containing 15N-
sphingolipid precursors, 13C-fatty acids, and 18O-cholestrol at the aforementioned concentration.  
On day 6, cells were passaged into dishes containing poly-L-lysine-coated 5 × 5-mm silicon wafer 
substrates. The following day, substrates were preserved with glutaraldehyde and osmium 
tetroxide as described.7,12 Incorporations of nitrogen-15 and oxygen-18 into the sphingolipids and 
cholesterol, respectively, were assessed using cells attached to the culture dish as previously 
reported.7,12  
SIMS 
Prior to SIMS analysis, samples were imaged on a JEOL 7000F analytical scanning electron 
microscope at 1 keV and a working distance of 10 mm. The samples were then coated with 3 nm 
of iridium (99.95%) with a Cressington 208HR high-resolution sputter coater equipped with a 
MTM-20 thickness controller. SIMS was performed on a Cameca NanoSIMS 50 at Lawrence 
Livermore National Laboratory. The 16O−, 18O−, 12C14N−, 12C15N−, and 32S- secondary ions, and 
secondary electrons were collected simultaneously. Cell membrane imaging was performed with 
a 0.17-pA, 16-keV 133Cs+ primary ion beam, where 12 replicate scans of 512 × 512 pixels with a 
dwell time of 0.5 ms/pixel were acquired for a 15 × 15-μm analysis region. Depth profiling was 
performed with a 1.137-pA, 16-keV 133Cs+ primary ion beam. Approximately 1620 replicate scans 
of 512 × 512 pixels with dwell time of 0.5 ms/pixel were acquired of a 10 × 10-μm region.  
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Image Analysis 
LIMAGE software (L. R. Nittler, Carnegie Institution of Washington) run on the PV-Wave 
platform (Visual Numerics, Inc.) was used to generate isotope enrichment images. The isotope 
enrichment is the 12C15N−/12C14N− or 18O-/16O- ratio divided by their terrestrial standard abundance 
ratio (0.00367 and 0.002005, respectively). Enrichment images showing the 15N-sphingolipid and 
18O-cholesterol distributions and 12C14N− ion images were constructed using a 5 x 5 pixel moving 
average smoothing algorithm.  
Compared to the depth profiling experiments, cell membrane imaging was performed with a 
lower dose of primary ions, so fewer secondary ions were detected at each pixel. Because ratioing 
to small numbers may amplify random signal fluctuations, the pixels where the counts of the 
naturally abundant ion were below a threshold value were masked so that they appear black in 
the isotope enrichment images of the plasma membrane. For the 15N-enrichment images, the 
masking threshold was set to four counts of 12C14N- ions/pixel, which is 5% of the maximum 12C14N- 
counts/pixel detected on the surface of the cell. For the 18O-enrichment images, a masking 
threshold of 5% of the maximum 16O- counts/pixel detected on the cell surface, which is one 16O- 
count/pixel, was insufficient to remove the pixel-to-pixel variation in 18O-enrichment that is 
characteristic of random variations in signal intensity. Therefore, a masking threshold of two 16O- 
counts/pixel, which is 10% of the maximum 16O- counts/pixel detected on the cell, was applied to 
the 18O-enrichment images of the plasma membrane. Masking thresholds were not applied to the 
depth profiling images because significantly more secondary ions were detected at each pixel.  
Three-dimensional (3D) representations of the 15N-sphingolipids and 18O-cholesterol within 
the cell were constructed by stacking subsequent images using the built-in 3D Viewer ImageJ 
plugin run in Image J.29 Each image in the stack was manually aligned in the x- and y-directions 
to correct for sample and stage drift during the depth profiling experiment. A transparency of 50% 
was applied to the stack for better visualization.  
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The approximate depth where each image was acquired was calculated from our raster area, 
primary ion beam current, and the average sputtering rate measured on other biological samples, 
as described.19 Sputtering rate was assumed to be constant at all positions in the sample. 
Differences between the rate of sputtering on these MDCK cells and the other biological samples, 
and potential changes in sputter rate caused by differences in chemical composition within the 
cell would reduce the accuracy of the estimated analysis depths and 3D renderings presented 
herein.  
3.3. RESULTS  
The distinct stable isotopes, nitrogen-15 and oxygen-18, were metabolically incorporated into 
MDCK cells as previously described.7,12 The cells were imaged with SEM under low-kV to identify 
well-preserved specimens for analysis with high-resolution SIMS. Figure 3.1 shows the whole, 
fixed MDCK cell, where the yellow outline indicates the approximate region that was analyzed 
with SIMS. No cracks or other blemishes are visible on the cell surface, indicating this cell was 
well-preserved.  
The cholesterol and sphingolipid distribution in the plasma membrane of the same MDCK 
cell was iridium coated and imaged with high-resolution SIMS using operating conditions that 
produced a sputtering depth of ~3 nm, estimated using the average sputtering rate determined 
for other biological samples.19 The secondary electron (SE) image that was collected in parallel 
with the secondary ions (Figure 3.2A) shows the morphology of the cell. The 18O-enrichment SIMS 
image (Figure 3.2B) shows the18O-cholesterol is relatively uniform within the plasma membrane, 
except for the dark region at the lower left corner of the image. This region appears dark because 
the 16O- ion counts were insufficient (≤2 counts/pixel) to calculate the 18O-enrichment at this tall 
region on cell (see the Materials and Methods for details). Large portions of this region also appear 
dark in the 15N-enrichment image (Figure 3.2C), which suggests that sample topography 
interfered with secondary ion collection at this site. Nonetheless, local elevations in 15N-
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enrichment that represent 15N-sphingolipid domains are visible on the cell (Figure 3.2C). The 15N-
sphingolipid-enriched features shown in Figure 3.2C do not correlate with projections or other 
distinct structures on the cell (Figure 3.2B), indicating they are not artifacts of cell topography. 
The finding of sphingolipid-enriched domains and a relatively uniform cholesterol distribution is 
consistent with the 18O-cholesterol and 15N-sphingolipid distributions we previously observed in 
the plasma membranes of mouse fibroblast cells.7-9 
The cholesterol and sphingolipid distributions within the MDCK cell were imaged after 
changing our analysis conditions to more rapidly sputter through the cell. Figure 3.3 shows the 
secondary electron, 18O-enrichment, 15N-enrichment, and 12C14N- secondary ion images that were 
acquired during the depth profiling analysis, revealing changes in cell morphology and 
composition with increasing depth from the cell’s surface. Note that the color bars that encode for 
the isotope enrichment at each pixel in Figure 3.3 have lower maxima than those shown in Figure 
3.2. Each of the images shown in Figure 3.3 was constructed using data from 10 raster planes, 
which is estimated to correspond to a thickness of approximately 37 nm. This estimated thickness 
was calculated from the analysis conditions and the average sputtering rate measured on other 
biological samples.19 Although this cell’s sputtering rate may differ from that measured on other 
biological samples or vary with intracellular location, this simple calculation yields a useful 
approximation of the position of the relatively large intracellular structures that were observed 
relative to the apical plasma membrane.  
Figure 3.3A, 3.3B, 3.3C, and 3.3D display the secondary electron, 18O-enrichment, and 15N-
enrichment, and 12C14N- secondary ion images that show sample morphology, 18O-cholesterol 
distribution, 15N-sphingolipid distribution, and 12C14N- counts, respectively, at a calculated depth 
of approximately 780 nm below the apical plasma membrane. Within this region, the 18O-
distribution is fairly uniform, except for the 18O-enriched region at the edge of the cell. Comparison 
to the secondary electron image (Figure 3.3A) indicates the cell was very thin at this 18O-enriched 
region. Therefore, this region is likely 18O-enriched because 18O-cholesterol in the plasma 
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membranes at both the top and bottom of the cell were detected. In contrast, ~0.5 - 2 µm regions 
enriched with 15N-sphingolipids are visible on the thicker regions of the cell (Figure 3.3C). These 
sphingolipid-rich regions do not correlate to the 15N-sphingolipid domains within the plasma 
membrane (Figure 3.2C). These features may be membrane-bound structures that contain 
sphingolipids in their lumens, or the sphingolipids may be confined to their membranes but our 
lateral resolution was insufficient to resolve their lumens.  
At an estimated sputtering depth of approximately 4 μm, much of the thin layer of material at 
the edge of the cell has been eroded away (Figure 3.3E). Features enriched with 18O-cholesterol 
become visible at this depth (Figure 3.3F), whereas the 15N-sphingolipid-rich features are less 
abundant (Figure 3.3G). The average 18O-enrichment in these features is nearly four times lower 
than that of the overlaying plasma membrane. This suggests that cholesterol is present at higher 
abundance in the plasma membrane than in intracellular structures, which is consistent with 
literature reports.30 The 18O-enriched features change with increasing depth. At an estimated 
depth of approximately 6 μm, a significant amount of erosion is visible (Figure 3.3I). Figure 3.3J 
shows that more 18O-cholesterol-rich features are visible at approximately 6 μm from the cell’s 
upper surface. Very few regions enriched in 15N-sphingolipids are visible at this depth (Figure 
3.3K), and those that are present are not co-localized with the 18O-rich regions. As shown in 
Figures 3.3G and 3.3K, 15N-sphingolipids appear to be deficient in many regions that are enriched 
with 18O-cholesterol. Interestingly, the 12C14N- secondary ion counts are also lower at the sites 
enriched with 18O-cholesterol (Figure 3.3H, L), which suggests that they contain low levels of 
nitrogen.  
3D visualization of a region that was estimated to span from approximately 3.7 to 6 μm below 
the cell surface was performed by stacking individual images acquired at the same sample 
location. Each layer was manually aligned with the previous image to correct for drift in the location 
of the analysis region, which produced an image stack that is uneven along its z-axis. Distinct 
cholesterol-rich features are clearly apparent (Figure 3.4A, B). Some of these features span the 
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entire depth of this analysis, which was calculated to be approximately 2.3 μm, and no decrease 
in their 18O-enrichment is visible. In contrast, the 15N-enriched areas that denote the presence of 
15N-sphingolipids are smaller than the 18O-enriched regions (Figure 3.4 C, D). Little co-localization 
was observed between the 18O-rich regions and the 15N-rich sites. The low counts of 12C14N-  
detected at the 18O-enriched features (Figure 3.3H, L) may suggest that they are lipid droplets.31 
Lipid droplets are cellular organelles that contain abundant triglycerides and sterol esters,32,33 
which are molecules that do not contain nitrogen. Lipid droplets range in size from 0.1 to 5 μm,34  
which is consistent with the sizes of the 18O-enriched features we observed. However, further 
studies are required to confirm the identity of these 18O-enriched intracellular structures.  
3.4. DISCUSSION 
The distribution of cholesterol between the plasma membrane and intracellular 
compartments is tightly controlled.30,35 The abundance of cholesterol in intracellular organelles 
has been linked to the membrane’s biophysical properties,36  and a variety of cellular processes, 
including signal transduction1,2 and membrane trafficking.3,4 Previous studies have employed 
fluorescent cholesterol analogs,37 fractionation procedures to separate cellular components of 
interest coupled with appropriate assays,38 and immunolabeling of cryosections of whole cells39 
to analyze the cholesterol distribution within cells.  
3D visualization of the cholesterol content of individual organelles within a single cell could 
improve our current understanding of cholesterol distribution by providing a fluorophore-free in 
situ method. Others have tracked 13C-fatty acid storage in lipid droplets within cell cultures and 
mouse tissue using high-resolution SIMS performed with a Cameca NanoSIMS.31,40,41 A similar 
study in which 13C-fatty acid incorporation was simultaneously imaged with 18O-cholesterol would 
be required to more definitively assess whether the 18O-enriched features we observed are lipid 
droplets. Alternatively, the presence of triglycerides and cholesterol esters might be assessed 
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without the need for labels with new time-of-flight secondary ion mass spectrometry (ToF-SIMS) 
instruments.  
While the relative distribution of cholesterol and sphingolipids within the cell volume can be 
clearly understood in this study, our estimates of sampling depth may be inaccurate if the sputter 
rate of this cell differs from that measured on other biological samples, or changes at different 
locations in the cell. This potential inaccuracy does not undermine the central conclusions of this 
study, but it would be a problem for a study in which the size of the structures or precise location 
is a part of the interpretation of the results. Measurements of sample height before and after SIMS 
analysis would enable more accurate determination of the depths of the observed intracellular 
structures. Chemical data could be used to account for changes in sputter rate in different 
structures. Topographic corrections could also help the viewer more readily understand more 
complex structures. Such corrections warp the image data to follow the surface topography, which 
can be visualized in the secondary electron images in this study (Figure 3.3). Some groups have 
used AFM to correct the z-axis for sample topography and construct more accurate 3D 
representations from the 2D data.42-44 At least one z-corrector toolbox has been developed, 
though it only works with IONTOF files.21 Recently, a Cameca NanoSIMS 50 was combined with 
high-resolution scanning probe microscopy to allow in-situ topographical imaging of the sample 
surface, which can then be automatically assembled into a 3D representation by an available 
software program.45 This in-situ approach has the advantage of being able to correct for any 
differences in sputter rate across the sample surface, which might occur when a region with a 
different chemical composition, such as a lipid droplet, comes to the surface. Such effects could 
be important if attempting to estimate the size of intercellular features with high precision.  
Summary and Conclusions 
Here we have demonstrated that high-resolution SIMS performed with a Cameca NanoSIMS 
50 enables the 3D visualization of submicron-sized features within a single cell. Using this 
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approach, we have observed interesting intracellular features with elevated 18O-cholesterol levels. 
Future work will focus on confirming the identity of these cholesterol-rich features, and locating 
specific organelles, such as endosomes, within the cell volume. 
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3.6. FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 SEM image of a MDCK cell. The approximate location that was depth profiled 
with high-resolution SIMS is outlined in yellow. 
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Figure 3.2 High-resolution SIMS images of the plasma membrane of a MDCK cell. Secondary electron 
image (A) of the surface of a MDCK cell acquired with the NanoSIMS instrument. The 18O-enrichment 
image (B) shows the distribution of metabolically incorporated 18O-cholesterol in the plasma 
membrane of the MDCK cell and on the adjacent substrate. The image appears black at the regions 
where the counts of 16O- ions were below the threshold (2 counts/pixel) required to calculate the 18O-
enrichment (lower left corner of the image). This primarily occurred at the tallest features within the 
analyzed region. The 15N-enrichment image (C) shows the distribution of metabolically labeled 15N-
sphingolipids in the plasma membrane. The image is black at the pixels where the 12C14N- ion counts 
were too low to calculate the 15N-enrichment (four 12C14N-- counts/pixel, see the Materials and Methods 
for details).    
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Figure 3.3 High-resolution SIMS images acquired at various depths within a MDCK cell. 
Images A – D are estimated to have been acquired after sputtering approximately 800 nm of 
material from the surface of the cell. Images E - H and I – L are estimated to have been 
acquired after sputtering approximately 4 μm and 6 μm, respectively, into the cell. (A, E, I) 
Secondary electron images show sample topology. (B, F, J) 18O-enrichment images reveal 
regions enriched with metabolically incorporated 18O-cholesterol within the cell. These large 
cholesterol-rich features begin to appear at an estimated depth of approximately 4 μm from 
the cell surface. (C, G, K) 15N-enrichment images show smaller regions enriched with 15N-
sphingolipids within the cell that do not correlate with the 18O-rich regions. (D, H, L) The 12C14N- 
secondary ion images show the 12C14N- counts were often very low at the 18O-enriched regions, 
which suggests that they have low nitrogen content. 
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Figure 3.4  3D renderings of the 18O-cholesterol and 15N-sphingolipid distributions in an 
approximately 2.3 μm-thick region in a MDCK cell were created by stacking 61 isotope 
enrichment images that were acquired over 24 h. Each of the 61 images in the stack consists 
of data from 10 raster planes. These images were aligned to correct for the sample and stage 
drift that occurred during the experiment, and a transparency of 50% was applied for better 
visualization. The 3D renderings were not adjusted to compensate for surface topography or 
potential changes in the sputter rate within the cell. The first and last images in each stack are 
estimated to have been acquired at approximately 3.7 and 6 μm, respectively, below the cell 
surface. Side (A) and top (B) view of the 3D rendering of the 18O-enrichment shows 18O-
cholesterol is concentrated in tubular projections that span the analysis depth. A combination 
of image alignment for drift correction and the 50% transparency gives the appearance of 
curvature along the z-axis (top left of A and bottom left of B). Side (C) and top (D) view of the 
3D distribution of 15N-enrichment shows smaller pockets of 15N-sphingolipids that do not 
correlate with the 18O-rich regions. 
90 
 
CHAPTER 4. 
NEUTRAL SPHINGOMYELINASE AND ITS POTENTIALLY IMPORTANT ROLE IN THE 
INFLUENZA VIRUS LIFECYCLE 
4.1. INTRODUCTION3 
The influenza virus is a common respiratory pathogen. Classic infection proceeds via entry 
and replication within ciliated columnar cells of the upper respiratory tract,1,2 causing symptoms 
of fever, cough, chills, myalgias, and malaise.3 The flu virus gains entry into these epithelial cells 
with its integral membrane protein, hemagglutinin (HA),4 which interacts with α-2,6-linked sialic 
acid found on multiple cell receptors.5-8 Upon making contact with the cell surface, the influenza 
virus gains entry into polarized cells through actin-dependent cytoskeleton remodeling.9,10 Actin 
is a major filament component of the cytoskeleton that has been linked to many aspects of 
influenza infection11 in addition to viral entry, such as playing a role in the clustering of viral HA at 
the cell plasma membrane during virus assembly12 and the trafficking of viral genetic 
components.13,14 Cytoskeletal remodeling is required in nearly every aspect of influenza 
replication, from particle entry at the start of infection to budding of the virion at the end of the 
virus life cycle.9,11  
One of the many components involved in cytoskeleton regulation is ceramide, a sphingolipid 
which functions as a second messenger.15-17 Ceramide triggers dephosphorylation of the 
regulator linkers ezrin, radixin, and moesin (ERM) proteins15-17 which link the plasma membrane  
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and the cortical actin cytoskeleton.18 Accumulation of ceramide in cells has been shown to induce 
actin cytoskeletal remodeling, characterized by the loss of cell polarization and motility.19 
Ceramide generation is controlled, in part, by neutral sphingomyelinase (nSMase) that cleaves 
sphingomyelin to produce ceramide and phosphocholine.20-23 Viral manipulation of ceramide 
through nSMase was recently highlighted when measles virus exposure was shown to induce 
ceramide accumulation at the plasma membrane of cells, indirectly causing actin-dependent 
cytoskeletal rearrangement.19 This increase was prevented through nSMase pharmacological 
inhibitors and short interfering RNA (siRNA) knock-down.19 Not only does ceramide trigger 
cytoskeletal activity, but also, alone, induces local membrane curvature, presumably due to its 
cone-shaped and relatively hydrophobic headgroup.24 These biophysical effects of ceramide in 
giant liposomes induces vesicle formation.25 This effect on membrane curvature is believed to be 
exploited by Neisseria gonorrhoeae for entry and was found dependent on SMase activity at the 
cell surface.24,26 Sphingomyelinase treatment has also been shown to induce endocytic vesicle 
formation in cells,27 presumably through its generation of ceramide. The effects of SMase and 
ceramide on endocytosis may be a necessary component for the entry of other pathogens, such 
as the influenza virus.  
Because the actin cytoskeleton has been intimately linked to many processes of the influenza 
lifecycle,9-14 the regulation of ceramide may be a key drug target to hinder replication. Inhibitors 
of SMases are abundant, with many displaying clinical relevance to treat a variety of disorders.28,29 
Here we show some of the effects of nSMase inhibition on the pathogenesis of the influenza virus. 
Pharmacologic inhibition of nSMase was found to have a protective effect, leading to less 
observable levels of cytopathic effect (CPE) in infected cells and decreased production of progeny 
virus in cell supernatant. These effects were not reproducible using targeted siRNA knock-down, 
however. Instead, evidence of viral manipulation of the nSMase genes was found, confounding 
interpretation of the data and highlighting the complexity of the influenza infection in MDCK cells.    
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4.2. MATERIALS AND METHODS 
Materials 
Trypsin was from Worthington Biochemical Corp. Fresh chicken blood was provided by the 
Department of Animal Sciences at the University of Illinois Urbana-Champaign. Bovine serum 
albumin (BSA) and other cell culture materials were purchased from Sigma. V-bottom plates were 
purchased from Sarstedt. PCR plates and other PCR supplies were obtained from Eppendorf. 
Chemicals for fixation were purchased from Electron Microscopy Sciences. Rabbit polyclonal 
primary antibody against influenza A virus nucleoprotein (NP) was purchased from Abcam. Goat 
secondary antibody against rabbit antibody with Alexa Fluor 488 conjugate and Hoechst 33342 
nuclear stain were purchased from Invitrogen. GW4869 was purchased from Cayman Chemical 
and desipramine-hydrochloride was obtained from Sigma.  
Cells and Viruses 
MDCK cells were obtained from the American Tissue Culture Collection (CCL-34) and grown 
in Dulbecco’s modified Eagle medium (DMEM), supplemented with 10% FBS, 104 units/mL 
penicillin G, and 10 mg/mL streptomycin. Influenza strain A/Aichi/2/68 (H3N2) was obtained from 
the American Tissue Culture Collection. Virus stocks were prepared by propagation of virus in 
MDCK cells under serum-free conditions in complete DMEM medium supplemented with 7.5% 
BSA, 25 mM HEPES buffer, and 2 µg/ml trypsin as previously described.30 Virus stocks were 
quantified by the 50% tissue culture infective dose (TCID50) in conjunction with the HA assay to 
determine infected wells30 and calculated by the method of Reed and Muench.31   
Confocal Microscopy 
For immunofluorescence, cells were fixed with 1% paraformaldehyde in DPBS (Dulbecco’s 
phosphate-buffered saline) for 20 min at room temperature and permeabilized with 0.1 Triton X-
100 in DPBS for 10 min on ice. After several washes with DPBS to remove the permeabilizing 
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agent, 1% BSA in DPBS was used to block for 30 min at room temperature. The primary antibody 
diluted in 1% BSA in DPBS was placed on cells for 1 h at room temperature, then was washed 
from the cells with 1% BSA in DPBS. Next, the secondary antibody diluted in DPBS with 1% BSA 
was added for 60 min at room temperature. Washes were carried out before and between 
antibodies to reduce non-specific antibody binding. Finally, the nuclear stain, Hoechst 33342, was 
added to cells for 10 min at room temperature. Antibody and nuclear stain concentrations were 
used following the recommendations from the manufacturers. Cells were washed and analyzed 
in DPBS. For qualitative analysis, images from the middle z-stack, unless otherwise noted, of 
representative cells were created using ImageJ. 
Real-Time RT-PCR 
RNA samples were isolated from MDCK cells using the RNeasy Mini Kit from Qiagen. 
Influenza primers were selected from published reports and purchased through Integrated DNA 
Technologies, Inc; for MDCK endogenous control GAPDH: 5′-AACATCATCCCTGCTTCCAC-3′ 
and 5′-GACCACCTGGTCCTCAGTGT-3’32 and the matrix (M) gene for influenza A: 5’-
AGATGAGTCTTCTAACCGAGGTCG-3’ and 5’-TGCAAAAACATCTTCAAGTCTCTG-3’.33 
Primers for dog SMPD2 (Cf_SMPD2_2_SG QuantiTect Primer Assay) and SMPD3 
(Cf_SMPD3_1_SG QuantiTect Primer Assay) were obtained from Qiagen and used following the 
manufacturer’s protocol. iTag Universal SYBR Green One-Step Kit from Bio-Rad was used in 
accordance with the manufacturer’s protocol using the sequences described previously. For 
influenza primers, each reaction was carried out with a 10 µL reaction mixture containing the 
primers mentioned previously using SYBR green dye in the reaction mixture. Briefly, the 
conditions were 50 °C for 10 min, 95 °C for 1 min, and 40 cycles of 95 °C for 15 s and 60 °C for 
30 s. The viral RNA levels, expressed as threshold CT values, were averaged from 3 biological 
replicates and normalized to the GAPDH RNA level as previously described.32 The SMPD2 and 
SMPD3 RNA levels were normalized to the GAPDH RNA level with indicated replicates.  
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RNA Interference 
The expressions of SMPD2 and SMPD3 in MDCK cells were manipulated using siRNAs. 
Three duplexes of siRNA against dog SMPD2 (XM_005627697) and SMPD3 (XM_5468632) were 
designed by Sigma. The designed sequences of siRNA duplexes against SMPD2 are 5’-
CUGGUUACGUGAUUGGCCUdTdT-3’ (sense), 5’-AGGCCAAUCACGUAACCAGdTdT-3’ 
(antisense), 5’-GGGAAGUUGCCAUACUCCUdTdT-3’ (sense), 5’-
AGGAGUAUGGCAACUUCCCdTdT-3’ (antisense), 5’-GUCUGUGCGUGUUCUCCAAdTdT-3’ 
(sense), 5’-UUGGAGAACACGCACAGACdTdT-3’ (antisense). The designed sequences of 
siRNA against SMPD3 are 5’-CAACCUCUACGACGAGGAAdTdT-3’ (sense), 5’-
UUCCUCGUCGUAGAGGUUGdTdT-3’ (antisense), 5’-GAGAUCUUAACUUUGACAAdTdT-3’ 
(sense), 5’-UUGUCAAAGUUAAGAUCUCdTdT-3’ (antisense), 5’-
CUCUUCUUCGCCAGCCGCUdTdT-3’ (sense), 5’-AGCGGCUGGCGAAGAAGAGdTdT-3’ 
(antisense). MDCK cells were transfected with siRNA against SMPD2, SMPD3, and MISSION® 
siRNA Universal Negative Control complexed with Lipofectamine RNAiMAX (Life Technologies) 
following the manufacturer’s protocol. Expression levels of SMPD2 and SMPD3 in transfected 
cells were 48% and 19%, respectively, of control transfections and were measured by RT-PCR 
48 h post transfection.  
Assessment of Influenza Virus Particle Production in the Presence of SMase Inhibition or Knock-
down   
Confluent MDCK cells were given media containing 5 µM GW4869 6 h prior to virus exposure 
or 10 µM desipramine 6 h prior to virus exposure. Following pre-treatment with inhibitors, cells 
were inoculated with influenza virus in virus medium at 0.1 multiplicity of infection (MOI; infectious 
virus as determined by TCID50 per number of cells) for approximately 30 min. Virus was washed 
from cells and fresh virus medium containing the inhibitors at the aforementioned concentrations 
was added. Cells were then incubated at 37 °C for 48 h and virus particles in the supernatant 
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were assessed using a HA assay as described above. For knock-down studies, cells were treated 
with siRNA following the manufacturer’s protocol. Briefly, cells were given siRNA in medium for 6 
h. Cells were then washed and incubated for 48 h prior to virus exposure. Knock-down cells were 
infected at 0.1 MOI and incubated for 48 h at 37°C. Following this incubation, supernatant was 
collected and tested by HA assay as previously described.  
Assessment of Influenza Virus Internalization 
Prior to virus exposure, cells were pre-treated with GW4869 for 2 h. During the last 30 min 
of treatment, cells were placed in 4 °C media with GW4869 for 30 min. Cells were then inoculated 
at 10 MOI for 45 minutes at 37°C. Following incubation, the virus was washed from cells and new 
media was added and incubated for an additional 45 min. After the inoculum was removed, cells 
were washed and fixed for 30 min in 1% paraformaldehyde, immunolabeled, and imaged with 
confocal microscopy as described above. For RT-PCR, identical infection parameters were 
followed and cells were lysed and analyzed for influenza M gene as described above. 
4.3. RESULTS 
To gauge whether nSMase inhibition had any effect on the replication of the influenza virus, 
we chose to use a commercially available, general nSMase inhibitor termed GW4869. As 
described by its manufacturer, GW4869 is permeable across the cell plasma membrane and acts 
as a non-competitive inhibitor of nSMases. Confluent MDCK cells were exposed to GW4869 6 h 
prior to virus infection in normal media at 5 µM, a concentration reported by others to inhibit the 
release of exosomes.34 Desipramine, an acid sphingomyelinase (ASMase) inhibitor, was also 
tested at 10 µM to gauge relative levels of virus production. Following pre-treatment with the 
inhibitors, cells were inoculated with influenza virus in virus medium at 0.1 MOI for approximately 
30 min. When the inoculum was complete, the virus was washed from cells and cells were 
incubated for 48 h as described (see Materials and Methods). Midway through the 48 h infection, 
cell images were taken to visually record the CPE due to virus replication.  
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As shown in Figure 4.1, control cells that were not treated with any SMase inhibitors show 
markedly more rounding and more detached floating cells are visible in these wells. Cells that 
were treated with desipramine or GW4869 appear to suffer less CPE, with more adhered cells 
showing normal morphologies. These observations suggest that the SMase inhibitors may 
provide a protective effect against influenza virus replication. The supernatant was removed and 
analyzed for virus particles using a HA assay 48 h.p.i. Figure 4.2 shows the results from 3 
biological replicate HA assay experiments. Treatment of the cells with either desipramine or 
GW4869 markedly reduced virus particle production. SMase inhibitors reduced the production of 
virus particles by as much as 80% of the control infections that did not receive any SMase 
inhibitors. Because both SMase inhibitors dramatically decreased influenza virus particle 
production, but the effects of ASMase on pathogen replication cycles has been heavily explored 
and are known to affect virus entry26,35,36 our subsequent work focused on probing the presently 
unknown biological significance of nSMase in virus infection. Therefore, we next set out to 
determine the exact step of the influenza virus lifecycle that was adversely affected by the nSMase 
inhibitor, GW4869. 
Influenza virus internalization was assessed using confocal microscopy as described in the 
Materials and Methods section. Figure 4.3 shows the effects of GW4869 on the internalization of 
the influenza virus. In these representative groups of images, each image represents 1 slice out 
of a z-stack. Each family of images represents the middle portion of the z-stack with 0.2 µm 
between each image. As shown, GW4869-treated cells appear to have less internalized virus. 
This was evident in all layers of the z-stack (Figure 4.3A-F compared to Figure 4.3G-L). From 
these results, we concluded that the influenza virus entry may be affected by GW4869 treatment.  
To confirm GW4869 treatment affected the virus internalization, we used real-time RT-PCR 
to quantitate the relative level of the matrix (M) gene from the influenza virus that was internalized 
in cells of DMSO- and drug-treated cells. Real-time RT-PCR was performed with previously 
published primers for the influenza M gene and MDCK GAPDH on cells subjected to the same 
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drug treatments and infection times as those used for the confocal microscopy experiments (see 
Materials and Methods). Figure 4.4 shows the relative abundance of the M gene found in 
GW4869-treated cells compared to DMSO-treated control cells. As evident, M gene levels were 
lower in the GW4869-treated cells, but this reduction was not statistically significant, indicating 
the absence of a statistically significant decrease in viral entry. In light of the qualitative decrease 
in virus particle entry observed in the confocal microscopy images, this finding was unexpected.  
However, it is possible that the decrease in virus particle entry observed with confocal microscopy 
also lacked statistical significance. 
Treatment with pharmacological inhibitors runs the risk for off-target effects on the cell. To 
ensure the effects were caused by inhibition of nSMases, we also attempted to verify our results 
by using targeted knock-down of two known nSMases, nSMase1 (SMPD2) and nSMase2 
(SMPD3). We chose these nSMases due to their reported ability to modulate ceramide 
abundance in vitro, although the ability of nSMase1 to alter ceramide levels in vivo is 
questionable.37 We were able to attain knock-down efficiencies of SMPD2 and SMPD3 at 48% 
and 19%, respectively, of control cells at 48 h following knock-down, just prior to infection with the 
influenza virus. To test whether the knock-down of SMPD2 and SMPD3 affected overall influenza 
virus replication, HA assays were conducted on knock-down samples 48 h.p.i. using the 
supernatant collected from infected cells. Briefly, knock-down cells were inoculated with influenza 
virus in virus medium at 0.1 MOI for approximately 30 min. Following the inoculum, the virus was 
washed from cells, fresh virus medium was added, and virus infection was allowed to proceed for 
48 h in the absence of additional siRNA. The results from two separate experiments are shown 
in Figure 4.5. As shown, the knock-down of either SMPD2 or SMPD3 did not appear to affect the 
production of virus. No statistically significant difference was detected in the levels of HA 
agglutination in either knock-down sample compared to control samples.  
The lack of a reduction in influenza virus particle production was not expected because it 
disagrees with the HA assays conducted on samples under pharmacological inhibition (Figure 
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4.2). This finding could indicate that GW4869 has an off-target effect unrelated to SMPD2 or 
SMPD3 that hinders influenza virus particle production. Another explanation is that SMPD2 and 
SMPD3 expression was not knocked down during the entire length of time that the virus infection 
was allowed to proceed in the absence of siRNA. The absence of such knock-down could be 
innate to the siRNA procedure for these targets, or it could result if the influenza virus specifically 
activates these nSMase genes during infection, effectively rescuing the knock-down and 
proceeding with replication as if the knock-down had not occurred. Indeed, the influenza virus is 
known to induce changes in the expression of some cellular genes, altering cellular mRNA 
levels.38 SMPD2 and SMPD3 may be uncharacterized influenza targets. To test this possibility, 
we infected MDCK cells with virus at 5 MOI, and quantified the cellular levels of SMPD2 and 
SMPD3 mRNA using real-time RT-PCR after several time points. Figure 4.6 shows that at 
approximated 2 h.p.i., the levels of SMPD2 and SMPD3 were nearly twice the level measured in 
mock-infected control cells. This may provide preliminary evidence of influenza-targeted 
regulation of SMPD2 and SMPD3, however, additional experiments would be required to establish 
reproducibility. Shorter timeframes may also provide a meaningful timeline to establish how 
quickly influenza can accomplish this manipulation.  
4.4. DISCUSSION AND FUTURE DIRECTIONS 
Here we present evidence of a potential influenza virus target. SMases have been linked to 
several pathogens19,26 and nSMase, in particular, is targeted by the measles virus.19 Because of 
its regulation of ceramide, nSMases were thought to be potentially necessary for the influenza 
lifecycle. The detrimental effects of pharmacological nSMase inhibitor, GW4869, on the 
replication cycle of the virus, are difficult to interpret as off-target effects that are not known could 
be the actual cause for the drug’s ability to hinder production of progeny virus in MDCK cells after 
several days of infection. Due to this, parallel validation knock-down studies were crucial. While 
evidence for nSMase knock-down directly affecting the influenza virus replication was unfounded, 
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the upregulation of the SMPD2 and SMPD3 mRNA levels observed following influenza infection 
may suggest either the cell was responsible for this up regulation as part of its immune response, 
or the virus upregulates these genes to promote its replication cycle. nSMase could potentially 
control key aspects of actin cytoskeleton remodeling indirectly through its regulation of 
ceramide.15,16,18 Ceramide could be a potential target of the influenza virus due to its central theme 
in the sphingolipid biosynthesis pathway,39 a known lipid pathway that is manipulated by the 
virus.40,41 At this time, it is difficult to say whether ceramide’s effects as a potential target of the 
virus are due to indirect off-targeting from influenza’s obvious manipulation of the sphingolipid 
biosynthesis pathway or a direct target as ceramide has been shown to directly manipulate key 
cellular functions the influenza virus needs to replicate. Our preliminary data on influenza’s 
potential manipulation of SMPD2 and SMPD3 might suggest that it is a direct target, although the 
reproducibility of this result must be verified before any firm conclusion can be drawn. 
The complexity of this system is further increased by the virus’s manipulation of cellular 
targets. Experiments are needed to determine shorter timeframes to limit the virus’s potential 
manipulation of the cell. We decided to test the levels of SMPD2 and SMPD3 at the earliest time 
point of 2 h because our previous experiments using confocal microscopy and real-time RT-PCR 
were conducted under similar timeframes. Finding similar levels of SMPD2 and SMPD3 at this 
time point compared to mock-infected control cells would imply the virus did not induce changes 
in the expression of these genes. However, we did see evidence of virus-induced changes in 
SMPD2 and SMPD3 expression at even this early time point and must reassess the time points 
that we presented here in testing of nSMases’ effects on viral entry. It is possible that the influenza 
virus may have manipulated host cell gene expression in a way that rescued the knock-down 
SMPD2 and SMPD3, resulting in similar virus production over the 48 h infection seen in the HA 
assays. Internalization experiments optimized for only a few minutes may reveal a more accurate 
depiction of nSMase’s effects on viral entry. At shorter timeframes the virus may not have enough 
time within the cell to significantly alter cellular targets.  
100 
 
Off-target effects that plague RNA interference also contribute to unknowns that must be 
addressed in future experiments. Genes with similar sequences have been found to be 
unintentionally targeted by siRNA, leading to expression patterns that were siRNA-specific 
instead of gene target-specific.42 These off-target effects can lead to changes in protein levels 
that are unrelated to the targeted gene.43 This can lead to the formation of incorrect conclusions 
based on the faulty assumption that the RNA interference was targeting only specific genes of 
interest. New genome-editing systems that do not rely on siRNA are now available. The clustered 
regularly interspaced short palindromic repeats with associated endonuclease (CRISPR/Cas9) 
system entails a Cas9 enzyme that binds DNA based on a small guiding RNA molecule that 
directs the Cas9 enzyme to a specific sequence of DNA. This system now is commercially 
available and can be used to knock-out or increase expression of target genes far more accurately 
than traditional siRNA knock-down. 
Another potential source of confusion that must be addressed in future experiments is 
whether changes in nSMase affect virus binding to the cell surface rather than endocytosis, 
distinctly different mechanisms. Perhaps the actual cause for decreased virus production is 
decreased binding of the virus to the cell surface, which in turn would lead to less virus 
endocytosed. Ceramide has been linked to several receptors and their clustering at the plasma 
membrane, triggering downstream receptor-specific effects.44,45 Although not specifically linked to 
any influenza-specific sialic acid receptors currently, this potential interaction cannot be ruled out. 
Ceramide’s actions on the clustering of receptors at the cell surface could change the binding of 
the virus. This is mechanistically different compared to decreased endocytosis. One way to test 
this is to use a virus-binding assay. Briefly, detached cells are incubated with virus under cold, 
endocytosis-inhibiting conditions. Bound virus is then detected with a biotinylated anti-virus 
antibody, which binds streptavidin conjugated to a dye probe that can then be detected with flow 
cytometry.46  
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While no firm conclusions can be drawn from the studies presented in this chapter, the 
preliminary work that was discussed highlights a potentially important novel drug target that could 
be used in the fight against the influenza virus. We discussed potential problems associated with 
our results that must be addressed and also detailed future experiments that would narrow future 
findings. Discussions of some of the potential reasoning behind this drug target were also 
explored. 
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4.6. FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Effects of desipramine and GW4869 on CPE following infection with the influenza virus 
at 0.1 MOI for 24 hours. A) Control cells following infection with influenza virus 24 h.p.i B) Cells 
pretreated with desipramine for 6 hours prior to and during infection 24 h.p.i. C) Cells pretreated 
with GW4869 for 6 hours prior to and during infection 24 h.p.i. 
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Figure 4.2 Untreated control MDCK cells and those pre-treated with the indicated SMase 
pharmacological inhibitors for 6 h prior to and during infection were infected with influenza at 0.1 
MOI. The levels of influenza virus particles collected in the supernatant were analyzed by HA 
assay 48 h.p.i. Error bars represent the standard deviation of 3 separate experiments. It was 
determined that the drugs lowered the amount of detected HA agglutination, indicating lower 
levels of influenza virus particles in the supernatant. 
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Figure 4.3 Effects of GW4869 on influenza virus entry shown in multiple images from a middle 
slice of z-stack images of representative control and treated cells. Cells were infected for 1.5 h 
prior to fixation and immunolabeling. A-F) Control MDCK cells pretreated with DMSO 2 h prior to 
infection. Image A represents the top image of a middle z-stack of images with each subsequent 
image taken 0.2 µm below. G-L) MDCK cells pretreated with GW4869 2 h prior to infection. Image 
G represents the top image of a middle z-stack of images with each subsequent image taken 0.2 
µm below. 
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Figure 4.4 Normalized M gene levels from influenza virus detected in DMSO-treated and 
GW4869-treated cells. GW4869 was given to cells 2 h prior to infection of influenza virus at 10 
MOI. Total RNA was extracted 1.5 h.p.i. It was concluded that GW4869 did not statistically inhibit 
virus entry. Data from 3 biological replicates run in triplicate.  
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Figure 4.5 MDCK cells given control siRNA and SMPD2 and SMPD3 knock-down MDCK cells 
were infected with influenza at 0.1 MOI. The levels of influenza virus particles in the samples were 
analyzed by HA assay 48 h.p.i. Error bars represent the standard deviation of 2 separate 
experiments. It was determined that knock-down of SMPD2 and SMPD3 did not inhibit the 
production of influenza virus particles found in the supernatant. 
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Figure 4.6 Relative fold change in nSMase gene levels in MDCK cells infected with influenza 
virus at 5 MOI over time. Data from 2 biological replicates run in triplicate. A) Relative fold change 
in SMPD2 mRNA in MDCK cells infected with influenza virus compared to mock infected cells. B) 
Relative fold change in SMPD3 mRNA in MDCK cells infected with influenza virus compared to 
mock infected cells.  
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CHAPTER 5. 
CONCLUSIONS AND FUTURE OBJECTIVES 
In Chapter Two we detailed how high-resolution secondary ion mass spectrometry (SIMS) 
was used to image influenza virus-infected MDCK cells. As described in previous chapters, earlier 
studies failed to directly compare the lipid profiles of the influenza virus envelope and the donor 
sites of the cell plasma membrane. Because our non-infected, control MDCK cells were shown to 
have sphingolipid-enriched domains that were not enriched with cholesterol, influenza’s supposed 
exploitation of such plasma membrane features was puzzling. With high-resolution SIMS, we 
were able to disprove this long hypothesized idea that influenza preferentially buds from lipid rafts 
and found that the influenza virus was not preferentially targeting sphingolipid-enriched domains 
in the plasma membrane of cells. Our results also indicated that some of the virus-infected cells 
did in fact have cholesterol-enriched sphingolipid domains. However, the influenza virus was 
overwhelmingly found in non-sphingolipid-enriched regions in the membranes of these cells as 
well. We believe that the cholesterol-enriched sphingolipid domains found in some infected cells 
suggest a potential consequence of lipid dysregulation that the virus induces for another purpose 
other than to induce cholesterol-enriched sphingolipid domains within the plasma membrane of 
cells. Many further studies are needed to reveal the complicated relationship between these lipids 
and the influenza virus. 
The findings we have presented diverge from a long-standing hypothesis regarding the 
influenza virus. Many previous studies implied support of the lipid raft hypothesis and influenza’s 
exploitation of these regions. Our research challenges this notion and truly highlights the need for 
an unobstructive method to study lipids, directly, in situ. Studying the native distributions of lipids 
with methods that do not lead to the alteration of their complex distributions is imperative to 
understand the intricate complexities of the cell. Elucidating the intricate and fragile lipid structures 
of the cell is important in the complete understanding of their functions, not only as they function 
within healthy cells, but also how and why the influenza virus uses them to further its replication 
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in the diseased cell. Future goals look towards total 3-dimensional (3D) lipid imaging of a cell. 
Future 3D imaging will revolutionize our understanding of the intricate network of these molecules 
and how their distribution may change during infection. 
Presented in Chapter Three are promising proof-of-concept experiments demonstrating the 
ability of high-resolution SIMS to produce images that can be reconstructed into 3D visualizations 
of a cell. Using iterative scanning over a defined region to visualize increasingly deeper layers, 
we discovered sub-micron features composed of cholesterol and sphingolipids. Many round, 
distinct cholesterol-rich features within the imaged portion of the cell were evident, with some 
spanning the entire approximate 2 μm-depth of analysis. Little co-localization was observed 
between the labeled cholesterol and labeled sphingolipids in many regions. We also detected an 
interesting cholesterol-enriched feature with low 12C14N- ions, which may suggest that they are 
lipid droplets.1 Further studies are needed to definitively confirm the identity of these intracellular 
structures. While we were able to successfully reconstruct the relative distribution of cholesterol 
and sphingolipids within a portion of the cell, the estimates of sampling depth that we presented 
may be inaccurate if the sputter rate changes during analysis of biological material. Future 
experiments should address the calibration of the sputtering depth within a cell with the primary 
ion dose, and investigate the extent that the sputter rate varies within the cell. Additionally, z-
correction methods that enable topographic corrections of the analyzed area should be 
developed.  
Lastly, in Chapter Four we presented our current findings on the importance of neutral 
sphingomyelinases (nSMases) in the influenza virus lifecycle. Pharmacological inhibition of 
nSMases during the influenza infection was found to have a protective effect, bolstering a link 
between the virus and nSMases’ function of regulating the sphingolipid, ceramide. However, the 
complexities of infection and the potential off-targeting effects of the pharmacological inhibitors 
complicated drawing conclusions from the findings. The use of RNA interference to bypass the 
drug’s potential off-target effects did not allow conclusion that nSMases are important in the 
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replication of the virus because RNA interference did not produce a statistically significant 
reduction in virus particle formation. Deeper probing revealed that influenza infection was 
correlated with an increased expression of mRNA encoding for nSMases. Consequently, genetic 
methods that efficiently knock-down SMPD2 and SMPD3 for the entire duration of influenza virus 
infection are needed to assess whether the reduced virus production induced by the 
pharmacological nSMase inhibitor was due to lower ceramide generation by nSMase or an off-
target effect. In addition, the increased levels of SMPD2 and SMPD3 mRNA detected 2 h after 
influenza infection suggest that the virus may target cellular genes related to nSMases, further 
confounding the interpretation of these results. Experiments that probe whether these increases 
in SMPD2 and SMPD3 mRNA levels are reproducible, and whether they result from the cells 
response to infection, or actual viral components are needed to assess the interesting possibility 
that nSMases are targeted by the influenza virus.  
In summary, this thesis has explored the role of host lipids in the influenza virus lifecycle. The 
influenza virus is a global health concern, rapidly mutating to resist preventative measures and 
clinical interventions aimed at stopping its spread.2,3 Focusing on the host lipids that are 
necessary in its replication cycle may lead to therapeutics, which target steps within the replication 
process that cannot be easily bypassed through mutations, lowering the potential for drug 
resistance. The ongoing fight against the influenza virus is fraught with challenges, but has the 
potential to save thousands of lives each year. 
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